GLP-1 Market
LLY $1136.11 ▼ -0.2% NVO $42.53 ▼ -2.1% PFE $27.55 ▼ -0.6% VKTX $29.95 ▼ -5.0% KLRA $13.45 ▼ -2.2% GPCR $38.95 ▲ +1.3% RHHBY $54.90 ▲ +0.2%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Cannabidiol

Company
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
87 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

87 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 16, 2026

Find a Clinical Trial Near Me

See recruiting studies for Cannabidiol and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03984565

    PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product

    Not yet reported Staci Gruber, Ph.D. 25 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Chronic Pain
    View official trial listing →
  • Recruiting NCT NCT04411225

    Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

    Not yet reported University of California, San Diego 120 participants Est. completion 2026-12 2 sites Stand-alone
    Other conditions: Early Psychosis
    View official trial listing →
  • Recruiting NCT NCT04550377

    Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI

    Not yet reported NYU Langone Health 120 participants Est. completion 2026-06 1 site
    Other conditions: Post Traumatic Stress Disorder, Traumatic Brain Injury
    View official trial listing →
  • Recruiting NCT NCT04587791

    Cannabidiol in Opioid Use Disorder and Chronic Pain

    Not yet reported Yale University 34 participants Est. completion 2026-08-31 1 site
    Substance use disorder Other conditions: Chronic Pain
    View official trial listing →
  • Recruiting NCT NCT04816994

    Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement

    Not yet reported Hadassah Medical Organization 200 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Acute Radicular Back Pain, Cannabis
    View official trial listing →
  • Recruiting NCT NCT04883255

    Cannabis Use, Cognition, and the Endocannabinoid System in HIV

    Not yet reported University of California, San Diego 138 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: HIV-1-infection
    View official trial listing →
  • Recruiting NCT NCT04992624

    Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee

    Not yet reported Steven E Harte, PhD 200 participants Est. completion 2027-06-30 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT05015439

    Cannabidiol (CBD) in Adults With ASD

    Not yet reported Johns Hopkins University 40 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Recruiting NCT NCT05020028

    Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis

    Not yet reported, Not yet reported NYU Langone Health 100 participants Est. completion 2027-09 1 site Stand-alone
    Other conditions: Knee Arthritis
    View official trial listing →
  • Recruiting NCT NCT05052541

    Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

    Not yet reported University of Colorado, Denver 157 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Back Pain, Neck Pain
    View official trial listing →
  • Recruiting NCT NCT05066308

    Cannabidiol for Reduction of Brain Neuroinflammation

    Not yet reported Massachusetts General Hospital 80 participants Est. completion 2026-12-15 1 site Stand-alone
    Other conditions: Back Pain, Depressive Symptoms
    View official trial listing →
  • Recruiting NCT NCT05269459

    Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults

    Not yet reported University of Nebraska 180 participants Est. completion 2029-04 1 site Stand-alone
    Other conditions: PTSD
    View official trial listing →
  • Recruiting NCT NCT05269628

    Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

    Not yet reported Tiffany J. Braley, MD, MS 166 participants Est. completion 2027-08-30 1 site Stand-alone
    Other conditions: Multiple Sclerosis, Sleep, Pain
    View official trial listing →
  • Recruiting NCT NCT05283382

    Cannabidiol Effects on Learning and Anxiety

    Not yet reported University of Connecticut 160 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: Anxiety and Fear
    View official trial listing →
  • Recruiting NCT NCT05337033

    Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial

    Not yet reported University of Manitoba 20 participants Est. completion 2025-12-31 3 sites Stand-alone
    Other conditions: Chronic Migraine
    View official trial listing →
  • Recruiting NCT NCT05389930

    Cannabis' Impact on Alcohol Consumption

    Not yet reported Brown University 350 participants Est. completion 2027-03-31 1 site
    Alcohol use disorder Other conditions: Cannabis Use, Cannabis
    View official trial listing →
  • Recruiting NCT NCT05445804

    Oral Cannabidiol for Tobacco Cessation

    Not yet reported Johns Hopkins University 50 participants Est. completion 2027-02-01 1 site Stand-alone
    Other conditions: Tobacco Use, Tobacco Smoking, Tobacco Dependence, Tobacco Use Disorder, Tobacco Use Cessation
    View official trial listing →
  • Recruiting NCT NCT05457465

    Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

    Not yet reported Mclean Hospital 25 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Recruiting NCT NCT05514899

    Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

    Not yet reported University of California, San Diego 90 participants Est. completion 2027-10-31 1 site
    Other conditions: HIV, Cannabis, THC, Neuroinflammatory Disease, Neuroinflammatory Response, Microbiome
    View official trial listing →
  • Recruiting NCT NCT05581368

    Studying the Effects of Cannabis on Vasculature

    London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 100 participants Est. completion 2025-12-30 1 site
    Cardiovascular disease Other conditions: Inflammation, Atherosclerosis
    View official trial listing →
  • Recruiting NCT NCT05613608

    Alcohol Use Disorder and Cannabidiol

    Not yet reported, Not yet reported University of Colorado, Denver 180 participants Est. completion 2027-04 1 site
    Alcohol use disorder
    View official trial listing →
  • Recruiting NCT NCT05649059

    Investigating the Effects of Cannabidiol on Social Anxiety Disorder

    Not yet reported Massachusetts Institute of Technology 50 participants Est. completion 2027-05 1 site
    Other conditions: Phobia, Social
    View official trial listing →
  • Recruiting NCT NCT05754840

    CANnabinoids in Pediatric ONCology

    Not yet reported, Not yet reported University of Manitoba 60 participants Est. completion 2026-12-31 3 sites Stand-alone
    Other conditions: Childhood Cancer, Cancer
    View official trial listing →
  • Recruiting NCT NCT05822362

    CBD for Individuals at Risk for Alzheimer's Disease

    Not yet reported University of Colorado, Denver 236 participants Est. completion 2029-04 1 site
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Recruiting NCT NCT05860699

    Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation : CBD-OH

    Not yet reported Assistance Publique - Hôpitaux de Paris 210 participants Est. completion 2026-05-23 12 sites Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Recruiting NCT NCT05867849

    Cannabidiol for Bipolar Depression (CBD-BD)

    Not yet reported University of British Columbia 360 participants Est. completion 2030-12 6 sites Stand-alone
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Recruiting NCT NCT05885542

    SCORE Emerging Adult Cannabis Use & Stress

    Not yet reported, Not yet reported Medical University of South Carolina 148 participants Est. completion 2028-07-31 1 site Stand-alone
    Other conditions: Cannabis Use Disorder
    View official trial listing →
  • Recruiting NCT NCT05985850

    Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy

    Not yet reported BC Centre on Substance Use 24 participants Est. completion 2027-03 1 site
    Substance use disorder Other conditions: Methadone, Cannabis, Fentanyl
    View official trial listing →
  • Recruiting NCT NCT06014424

    Cannabidiol Medication Intervention Trial

    Not yet reported Sunnybrook Health Sciences Centre 40 participants Est. completion 2026-12-29 5 sites
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT06097533

    Improvement of Quality of Life by Cannabinoids in Oncologic Patients

    Not yet reported University Hospital Schleswig-Holstein 170 participants Est. completion 2026-11-30 4 sites Stand-alone
    Other conditions: Medical Oncology, Palliative Care, Quality of Life, Cannabinoids
    View official trial listing →
  • Recruiting NCT NCT06099379

    Modulation of THC Effects by CBD: a Dose-ranging Study

    Not yet reported, Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Cannabis, THC
    View official trial listing →
  • Recruiting NCT NCT06107062

    Longitudinal Outpatient Treatment for Cannabis Use Disorder

    Not yet reported University of Colorado, Boulder 165 participants Est. completion 2029-03-31 1 site Stand-alone
    Other conditions: Cannabis Use Disorder
    View official trial listing →
  • Recruiting NCT NCT06113237

    Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy

    Jazz Pharmaceuticals 50 participants Est. completion 2033-08-31 2 sites
    Other conditions: Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse, Pregnancy
    View official trial listing →
  • Recruiting NCT NCT06129591

    Topical CBD Scar Healing Study

    Not yet reported University of Oklahoma 22 participants Est. completion 2028-07 1 site
    Other conditions: Paramedian Forehead Flap
    View official trial listing →
  • Recruiting NCT NCT06148038

    CBD for Breast Cancer Primary Tumors

    Not yet reported Medical University of South Carolina 84 participants Est. completion 2029-03-25 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06213233

    MIVetsCan: Cannabidiol (CBD)-Care Trial

    Not yet reported Kevin Boehnke 468 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Pain, Chronic
    View official trial listing →
  • Recruiting NCT NCT06218056

    Cannabidiol for Reducing Cigarette Use

    Not yet reported University of California, Los Angeles 120 participants Est. completion 2026-12-31 1 site
    Other conditions: Tobacco Use Disorder, Tobacco Smoking, Tobacco Dependence
    View official trial listing →
  • Recruiting NCT NCT06234631

    Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty

    Not yet reported Chad Brummett 380 participants Est. completion 2029-01 2 sites Stand-alone
    Osteoarthritis Other conditions: Knee Replacement Surgery
    View official trial listing →
  • Recruiting NCT NCT06261489

    Cannabis (THC vs. CBD) in Multiple Sclerosis

    Not yet reported University of Calgary 30 participants Est. completion 2027-09-30 2 sites Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Recruiting NCT NCT06261502

    Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome

    Not yet reported Université de Sherbrooke 40 participants Est. completion 2028-12-01 1 site
    Other conditions: Fragile X Syndrome
    View official trial listing →
  • Recruiting NCT NCT06266611

    Cannabis for Palliative Care in Cancer

    Not yet reported University of Colorado, Boulder 185 participants Est. completion 2028-06-30 1 site Stand-alone
    Other conditions: Sleep, Anxiety, Depression, Pain
    View official trial listing →
  • Recruiting NCT NCT06283862

    MIVetsCan: Can-Coach Trial (Phase 2)

    Not yet reported University of Michigan 468 participants Est. completion 2028-07-31 1 site
    Other conditions: Chronic Pain
    View official trial listing →
  • Recruiting NCT NCT06290063

    Cannabidiol and Older Adult Cannabis Users

    Not yet reported University of Colorado, Boulder 385 participants Est. completion 2028-08-31 1 site Stand-alone
    Other conditions: Sleep, Anxiety, Depression, Pain
    View official trial listing →
  • Recruiting NCT NCT06333041

    Study of Cannabidiol in Sanfilippo Syndrome

    Not yet reported, Not yet reported Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 35 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Sanfilippo Syndrome, Mucopolysaccharidosis III
    View official trial listing →
  • Recruiting NCT NCT06381180

    Warrior CARE: Cannabis Behavioral Health

    Not yet reported, Not yet reported Wayne State University 500 participants Est. completion 2030-12-31 1 site Stand-alone
    Other conditions: Post Traumatic Stress Disorder, Cannabis Use, Suicide, Veterans, Marijuana
    View official trial listing →
  • Recruiting NCT NCT06381791

    CBD for Pain Following Orthopedic Shoulder Surgery

    Not yet reported, Not yet reported The Methodist Hospital Research Institute 80 participants Est. completion 2027-12-30 1 site Stand-alone
    Osteoarthritis Other conditions: Rotator Cuff Injuries
    View official trial listing →
  • Recruiting NCT NCT06393101

    The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome

    Not yet reported University of California, San Diego 52 participants Est. completion 2029-06-01 2 sites Stand-alone
    Other conditions: Complex Regional Pain Syndrome
    View official trial listing →
  • Recruiting NCT NCT06414473

    CBD for Knee Osteoarthritis

    Not yet reported, Not yet reported University of Florida 30 participants Est. completion 2026-12-31 1 site
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT06448923

    Cannabidiol After Multi-Trauma for Pain and Opioid Therapy

    Not yet reported Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 225 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Fracture
    View official trial listing →
  • Recruiting NCT NCT06477406

    Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis

    Not yet reported Mclean Hospital 30 participants Est. completion 2026-10 1 site Stand-alone
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT06512389

    Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder

    Not yet reported Centre for Addiction and Mental Health 36 participants Est. completion 2026-06-30 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Recruiting NCT NCT06518434

    A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients

    Not yet reported University Medical Center Groningen 20 participants Est. completion 2027-04-15 1 site
    Other conditions: Hepatocellular Carcinoma, Cannabis
    View official trial listing →
  • Recruiting NCT NCT06542445

    The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD

    Not yet reported Bazelet Nehushtan LtD. 120 participants Est. completion 2026-09-22 1 site
    Other conditions: Attention Deficit Hyperactivity Disorder (ADHD)
    View official trial listing →
  • Recruiting NCT NCT06544291

    Combined THC and CBD for OUD and Chronic Pain

    Not yet reported Yale University 147 participants Est. completion 2028-01-28 1 site
    Substance use disorder Other conditions: Chronic Pain
    View official trial listing →
  • Recruiting NCT NCT06569394

    A Study of Cannabidiol in Young Adult Cannabis Users

    Not yet reported University of Colorado, Denver 200 participants Est. completion 2028-06-30 1 site
    Other conditions: Cannabis Use Disorder
    View official trial listing →
  • Recruiting NCT NCT06574100

    Relative Bioavailability of Two Orally Administered CBD Formulations in Healthy Male Adults

    Not yet reported University of Saskatchewan 20 participants Est. completion 2025-11 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Recruiting NCT NCT06575751

    Cannabidiol and Cannabis Concentrate Users

    Not yet reported University of Colorado, Denver 120 participants Est. completion 2028-06-30 1 site
    Other conditions: Cannabis Use Disorder
    View official trial listing →
  • Recruiting NCT NCT06589258

    Cannabidiol Into Breastmilk

    Not yet reported Centre Hospitalier Régional d'Orléans 60 participants Est. completion 2028-10 1 site
    Other conditions: Breast Feeding
    View official trial listing →
  • Recruiting NCT NCT06629389

    Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms

    Not yet reported Laboratorio Elea Phoenix S.A. 88 participants Est. completion 2026-11 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06686914

    The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex

    Not yet reported West Virginia University 300 participants Est. completion 2029-05-01 1 site
    Other conditions: Cannabidiol Effects, Driving Performance
    View official trial listing →
  • Recruiting NCT NCT06692933

    Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel

    Not yet reported Washington State University 24 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Interaction
    View official trial listing →
  • Recruiting NCT NCT06708299

    CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

    Not yet reported Cardiol Therapeutics Inc. 110 participants Est. completion 2026-10-21 27 sites
    Other conditions: Recurrent Pericarditis
    View official trial listing →
  • Recruiting NCT NCT06731894

    Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

    Not yet reported City of Hope Medical Center 120 participants Est. completion 2028-01-07 2 sites Stand-alone
    Other conditions: Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy, Colon Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06778564

    Stratification and Treatment in Early Psychosis Study - ENHANCE

    Not yet reported University of Oxford 250 participants Est. completion 2029-02 17 sites Stand-alone
    Other conditions: Psychosis, First Episode Psychosis, Psychotic Disorders, Psychotic Episode
    View official trial listing →
  • Recruiting NCT NCT06840899

    CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury

    Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2027-05 1 site Stand-alone
    Other conditions: Supra-sacral Spinal Cord Injury, Spinal Cord Injury, Urinary Incontinence
    View official trial listing →
  • Recruiting NCT NCT06845124

    A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence

    Not yet reported Central Institute of Mental Health, Mannheim 150 participants Est. completion 2028-09-30 2 sites Stand-alone
    Other conditions: Alcohol Addiction, Alcoholism
    View official trial listing →
  • Recruiting NCT NCT06878417

    Cannabinoids for Osteoarthritis Pain Effectiveness Trial

    Not yet reported University Health Network, Toronto 100 participants Est. completion 2027-02-28 3 sites Stand-alone
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT06930703

    Cannabidiol in Sickle Cell Disease

    Not yet reported, Not yet reported Icahn School of Medicine at Mount Sinai 52 participants Est. completion 2027-02-01 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT06940674

    Adjunctive Cannabidiol for Recovery From Opioid Study

    Not yet reported Icahn School of Medicine at Mount Sinai 450 participants Est. completion 2027-08-15 2 sites Stand-alone
    Substance use disorder
    View official trial listing →
  • Recruiting NCT NCT06946940

    Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia

    Not yet reported Rambam Health Care Campus 150 participants Est. completion 2027-05 1 site
    Other conditions: Fibromyalgia
    View official trial listing →
  • Recruiting NCT NCT07016971

    CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy

    Not yet reported Milton S. Hershey Medical Center 12 participants Est. completion 2029-07-03 1 site
    Other conditions: Chemotherapy-Induced Peripheral Neuropathy
    View official trial listing →
  • Recruiting NCT NCT07069478

    Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms

    Not yet reported University of Minnesota 125 participants Est. completion 2028-12-31 1 site
    Other conditions: CBD, Cannabidiol, Stress, Acute Stress Reaction
    View official trial listing →
  • Recruiting NCT NCT07093138

    Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks

    Not yet reported Alasht Pharmed 30 participants Est. completion 2025-09-16 1 site Stand-alone
    Other conditions: Migraine Disorders
    View official trial listing →
  • Recruiting NCT NCT07123467

    Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

    Not yet reported Wayne State University 90 participants Est. completion 2027-08-31 1 site Stand-alone
    Other conditions: Generalized Anxiety Disorder (GAD), Anxiety Disorders
    View official trial listing →
  • Recruiting NCT NCT07167446

    Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

    Not yet reported Fox Chase Cancer Center 30 participants Est. completion 2028-09-07 1 site Stand-alone
    Other conditions: Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients, Metastatic Colorectal Cancer (CRC), Peripheral Neuropathy Due to Chemotherapy
    View official trial listing →
  • Recruiting NCT NCT07199218

    Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism

    Not yet reported Bazelet Nehushtan LtD. 78 participants Est. completion 2028-03-03 1 site Stand-alone
    Other conditions: Autism, Autism Spectrum Disorder
    View official trial listing →
  • Recruiting NCT NCT07233239

    A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

    Not yet reported Jazz Pharmaceuticals 100 participants Est. completion 2027-11-29 24 sites
    Other conditions: Focal Seizures
    View official trial listing →
  • Recruiting NCT NCT07245238

    Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma

    Not yet reported Khon Kaen University 36 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Mediciine, Systemic Sclerosis (SSc), Intervention Study
    View official trial listing →
  • Recruiting NCT NCT07278505

    Study of Cannabidiol and Neuroimaging on Stress

    Not yet reported, Not yet reported Icahn School of Medicine at Mount Sinai 160 participants Est. completion 2030-02-28 1 site Stand-alone
    Other conditions: Early Life Adversity, Trauma, Stress
    View official trial listing →
  • Recruiting NCT NCT07279558

    Cannabidiol and Alcohol Use Disorder Phenotypes

    Not yet reported University of Colorado, Denver 150 participants Est. completion 2029-08-31 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Recruiting NCT NCT07298408

    Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

    Not yet reported, Not yet reported Florida A&M University 20 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies
    View official trial listing →
  • Recruiting NCT NCT07434895

    Repeated CBD Administration and Cannabis Outcomes

    Not yet reported Hannah Harris 23 participants Est. completion 2029-12-01 1 site Stand-alone
    Other conditions: Cannabis, Abuse Liability, Experimental Pain in Healthy Human Participants
    View official trial listing →
  • Recruiting NCT NCT07592390

    Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)

    Not yet reported, Not yet reported Universidade do Sul de Santa Catarina 60 participants Est. completion 2026-12-18 1 site Stand-alone
    Other conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
    View official trial listing →
  • Recruiting NCT NCT07656350

    Challenging the Endocannabinoid System in Sleep Restricted Healthy Volunteers to Modulate Physiological Arousal (CANISLEEP) Study

    Not yet reported King's College London 60 participants Est. completion 2027-12-31 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Recruiting NCT NCT07668856

    Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials

    Not yet reported UMC Utrecht 50 participants Est. completion 2027-12 1 site
    Other conditions: Refractory Epilepsy in Children, Refractory Epilepsy, Epilepsy
    View official trial listing →
  • Recruiting NCT NCT07696871

    Cannabidiol Oil for Treatment-Resistant Major Depression

    Not yet reported, Not yet reported Universidade do Sul de Santa Catarina 120 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Major Depressive Disorder (MDD), Treatment-resistant Depression (TRD)
    View official trial listing →
  • Recruiting NCT NCT07728695

    Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain

    Not yet reported, Not yet reported Staci Gruber, Ph.D. 60 participants Est. completion 2029-01 1 site
    Other conditions: Endometriosis, Adenomyosis, Chronic Pelvic Inflammatory Disease
    View official trial listing →
  • Completed NCT NCT00309413

    A Clinical Trial on the Antipsychotic Properties of Cannabidiol

    Not yet reported University of Cologne 29 participants Est. completion 2008-07 1 site
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00391079

    Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS

    Not yet reported GW Pharmaceuticals Ltd 339 participants Est. completion 2008-09 6 sites Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00530764

    A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

    Not yet reported GW Pharmaceuticals Ltd 360 participants Est. completion 2010-01 110 sites Stand-alone
    Other conditions: Palliative Care, Pain, Cancer
    View official trial listing →
  • Completed NCT NCT00588731

    Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia

    Not yet reported Yale University 41 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00628290

    Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis

    Not yet reported University of Cologne 42 participants Est. completion 2008-03 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00674609

    A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy

    Not yet reported Jazz Pharmaceuticals 177 participants Est. completion 2004-03 1 site Stand-alone
    Other conditions: Palliative Care, Pain, Cancer
    View official trial listing →
  • Completed NCT NCT00675948

    Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain

    Not yet reported Jazz Pharmaceuticals 43 participants Est. completion 2006-09 1 site Stand-alone
    Other conditions: Pain, Cancer
    View official trial listing →
  • Completed NCT NCT00678795

    A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis

    Not yet reported Jazz Pharmaceuticals 135 participants Est. completion 2005-10 1 site Stand-alone
    Other conditions: Detrusor Overactivity, Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00681538

    A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)

    Not yet reported Jazz Pharmaceuticals 572 participants Est. completion 2009-01 1 site Stand-alone
    Other conditions: Spasticity, Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00702468

    Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis

    Not yet reported Jazz Pharmaceuticals 36 participants Est. completion 2009-01 1 site Stand-alone
    Other conditions: Spasticity, Multiple Sclerosis
    View official trial listing →
  • Withdrawn NCT NCT00916201

    Evaluation Study of New Compounds With Potential Use in Schizophrenia

    Not yet reported Central Institute of Mental Health, Mannheim Est. completion 2025-01-31 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01037322

    Cannabidiol for Inflammatory Bowel Disease

    Not yet reported, Not yet reported Meir Medical Center 20 participants Est. completion 2012-09 1 site
    Other conditions: Crohn's Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01180374

    The Effects of Cannabidiol and ∆-9-THC in Humans

    Not yet reported Yale University 27 participants Est. completion 2014-10-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01217112

    GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes

    Not yet reported Jazz Pharmaceuticals 62 participants Est. completion 2012-09 5 sites
    Type 2 diabetes Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT01262651

    Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

    Not yet reported GW Pharmaceuticals Ltd 397 participants Est. completion 2015-07-02 72 sites Stand-alone
    Other conditions: Pain, Advanced Cancer
    View official trial listing →
  • Completed NCT NCT01311778

    Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse

    Not yet reported Hurd,Yasmin, Ph.D. 18 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Opiate Addiction
    View official trial listing →
  • Completed NCT NCT01337089

    Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

    Not yet reported Jazz Pharmaceuticals 660 participants Est. completion 2016-01-27 128 sites Stand-alone
    Other conditions: Pain, Advanced Cancer
    View official trial listing →
  • Completed NCT NCT01361607

    Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer

    Not yet reported Jazz Pharmaceuticals 399 participants Est. completion 2014-11-24 68 sites Stand-alone
    Other conditions: Pain, Advanced Cancer
    View official trial listing →
  • Status unknown NCT NCT01385124

    Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation

    Not yet reported, Not yet reported Rabin Medical Center 30 participants 1 site Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT01424566

    A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer

    Not yet reported Jazz Pharmaceuticals 406 participants Est. completion 2015-12-28 65 sites Stand-alone
    Other conditions: Pain, Advanced Cancer
    View official trial listing →
  • Completed NCT NCT01502046

    Neuroprotection by Cannabinoids in Huntington's Disease

    Not yet reported Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 25 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Huntington's Disease
    View official trial listing →
  • Completed NCT NCT01562314

    A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

    Not yet reported GW Research Ltd 60 participants Est. completion 2014-08-05 8 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01599234

    A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis

    Not yet reported Jazz Pharmaceuticals 337 participants Est. completion 2005-12 1 site Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01604265

    A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis

    Not yet reported Jazz Pharmaceuticals 66 participants Est. completion 2002-08 1 site Stand-alone
    Other conditions: Multiple Sclerosis, Neuropathic Pain
    View official trial listing →
  • Completed NCT NCT01605539

    Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans

    Not yet reported Hurd,Yasmin, Ph.D. 10 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Opiate Addiction
    View official trial listing →
  • Completed NCT NCT01606137

    A Study of the Long-term Safety of Sativex Use

    Not yet reported Jazz Pharmaceuticals 507 participants Est. completion 2004-12 1 site Stand-alone
    Other conditions: Multiple Sclerosis, Spasticity, Pain
    View official trial listing →
  • Completed NCT NCT01606176

    A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin

    Not yet reported Jazz Pharmaceuticals 70 participants Est. completion 2002-08 1 site Stand-alone
    Other conditions: Pain, Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01606189

    A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain

    Not yet reported Jazz Pharmaceuticals 48 participants Est. completion 2002-09 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT01606202

    A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury

    Not yet reported Jazz Pharmaceuticals 116 participants Est. completion 2005-01 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT01610687

    A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

    Not yet reported Jazz Pharmaceuticals 137 participants Est. completion 2005-02 1 site
    Other conditions: Multiple Sclerosis, Spasticity
    View official trial listing →
  • Completed NCT NCT01610713

    An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

    Not yet reported Jazz Pharmaceuticals 154 participants Est. completion 2002-07 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01747850

    Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence

    Not yet reported Centre for Addiction and Mental Health 45 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Cannabis Dependence
    View official trial listing →
  • Completed NCT NCT01748799

    Fixed or Self-Titrated Dosages of Sativex on Cannabis Users

    Not yet reported Centre for Addiction and Mental Health 16 participants Est. completion 2014-09 1 site
    Other conditions: Cannabis Dependence
    View official trial listing →
  • Completed NCT NCT01812603

    A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma

    Not yet reported, Not yet reported Jazz Pharmaceuticals 6 participants Est. completion 2016-06 5 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01812616

    A Safety Study of Sativex Compared With Placebo (Both With Dose-intense Temozolomide) in Recurrent Glioblastoma Patients

    Not yet reported, Not yet reported Jazz Pharmaceuticals 21 participants Est. completion 2016-06 11 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01844687

    Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana

    Not yet reported National Institute on Drug Abuse (NIDA) 50 participants Est. completion 2014-10 3 sites
    Other conditions: Smoking, Marijuana
    View official trial listing →
  • Completed NCT NCT01887301

    Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients

    Not yet reported Jazz Pharmaceuticals 32 participants Est. completion 2014-05 2 sites
    Other conditions: Hepatic Impairment
    View official trial listing →
  • Completed NCT NCT01893424

    Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)

    Not yet reported Hadassah Medical Organization 12 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT01898520

    A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years

    Not yet reported Jazz Pharmaceuticals 72 participants Est. completion 2017-03 14 sites
    Other conditions: Cerebral Palsy
    View official trial listing →
  • Completed NCT NCT02006628

    A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder

    Not yet reported Jazz Pharmaceuticals 88 participants Est. completion 2015-01-08 14 sites
    Other conditions: Schizophrenia, Schizophrenia-related Psychotic Disorder
    View official trial listing →
  • Completed NCT NCT02044809

    Cannabidiol: a Novel Intervention for Cannabis Use Problems?

    Not yet reported University College, London 82 participants Est. completion 2017-06-05 1 site Stand-alone
    Other conditions: Cannabis Use Disorder
    View official trial listing →
  • Completed NCT NCT02051387

    Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study

    Not yet reported Central Institute of Mental Health, Mannheim 74 participants Est. completion 2017-08 2 sites Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02073474

    An Observational Post-Marketing Safety Registry of Sativex®

    Jazz Pharmaceuticals 978 participants Est. completion 2015-01
    Other conditions: Multiple Sclerosis, Diabetes, Cancer, Neuropathic Pain
    View official trial listing →
  • Status unknown NCT NCT02083874

    Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study

    Not yet reported The University of New South Wales 5 participants Est. completion 2014-12
    Other conditions: Cannabis Use Disorder
    View official trial listing →
  • Terminated NCT NCT02088060

    A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients

    Not yet reported Central Institute of Mental Health, Mannheim 150 participants Est. completion 2024-09-16 6 sites Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02091206

    A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)

    Not yet reported Jazz Pharmaceuticals 34 participants Est. completion 2015-03-09 11 sites Stand-alone
    Other conditions: Epilepsy, Dravet Syndrome
    View official trial listing →
  • Completed NCT NCT02091375

    Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

    Not yet reported Jazz Pharmaceuticals 120 participants Est. completion 2015-11-26 22 sites Stand-alone
    Other conditions: Epilepsy, Dravet Syndrome
    View official trial listing →
  • Completed NCT NCT02112292

    The Role of the Endocannabinoid System in Sweet Taste Intensity and Liking

    Not yet reported Wageningen University 10 participants Est. completion 2015-04-16 1 site Stand-alone
    Other conditions: Sensory Science
    View official trial listing →
  • Completed NCT NCT02224560

    Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

    Not yet reported Jazz Pharmaceuticals 225 participants Est. completion 2016-05-19 29 sites Stand-alone
    Other conditions: Epilepsy, Lennox Gastaut Syndrome
    View official trial listing →
  • Completed NCT NCT02224573

    An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes

    Not yet reported GW Research Ltd 681 participants Est. completion 2020-09-24
    Other conditions: Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome
    View official trial listing →
  • Completed NCT NCT02224690

    A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

    Not yet reported Jazz Pharmaceuticals 171 participants Est. completion 2016-03-18 24 sites Stand-alone
    Other conditions: Epilepsy, Lennox-Gastaut Syndrome
    View official trial listing →
  • Completed NCT NCT02224703

    GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

    Not yet reported Jazz Pharmaceuticals 199 participants Est. completion 2018-04-09 38 sites Stand-alone
    Other conditions: Epilepsy, Dravet Syndrome
    View official trial listing →
  • Completed NCT NCT02229032

    Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population

    University of Colorado, Denver 19 participants Est. completion 2017-07 1 site
    Other conditions: Dravet Syndrome
    View official trial listing →
  • Status unknown NCT NCT02255292

    A Study: Pure CBD as Single-agent for Solid Tumor.

    Not yet reported Hadassah Medical Organization 60 participants Est. completion 2015-07 Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT02283281

    Anesthetic Premedication With a Cannabis Extract (Cannapremed)

    Not yet reported, Not yet reported Hadassah Medical Organization 200 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Pain, Postoperative, Postoperative Nausea and Vomiting, Anxiety
    View official trial listing →
  • Completed NCT NCT02286986

    Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

    Not yet reported University of Utah 26 participants Est. completion 2019-06-13 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02291536

    Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

    Not yet reported Central Institute of Mental Health, Mannheim 20 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy Humans
    View official trial listing →
  • Completed NCT NCT02291562

    Effects of THC and CBD on Human Episodic Memory Function

    Not yet reported Central Institute of Mental Health, Mannheim 20 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT02318537

    Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome

    Not yet reported INSYS Therapeutics Inc Est. completion 2018-06-30 Stand-alone
    Other conditions: Lennox-Gastaut Syndrome
    View official trial listing →
  • Withdrawn NCT NCT02318563

    Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome

    Not yet reported INSYS Therapeutics Inc Est. completion 2018-06-17 Stand-alone
    Other conditions: Dravet Syndrome
    View official trial listing →
  • Completed NCT NCT02318602

    Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

    Not yet reported INSYS Therapeutics Inc 52 participants Est. completion 2017-06-22 11 sites Stand-alone
    Other conditions: Seizures
    View official trial listing →
  • Completed NCT NCT02324673

    Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders

    Not yet reported, Not yet reported INSYS Therapeutics Inc 61 participants Est. completion 2016-05-09 10 sites Stand-alone
    Other conditions: Seizures
    View official trial listing →
  • Completed NCT NCT02332655

    Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

    Not yet reported, Not yet reported Anne Comi, MD 5 participants Est. completion 2021-04 1 site Stand-alone
    Other conditions: Sturge-Weber Syndrome
    View official trial listing →
  • Status unknown NCT NCT02392780

    Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease

    Not yet reported moshe yeshurun 10 participants 1 site Stand-alone
    Other conditions: Acute-graft-versus-host Disease
    View official trial listing →
  • Available NCT NCT02397863

    Epidiolex and Drug Resistant Epilepsy in Children

    Augusta University Est. completion 2020-01 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Withdrawn NCT NCT02432612

    A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer

    Not yet reported GW Pharmaceuticals Ltd Est. completion 2016-10 Stand-alone
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT02447198

    Cannabidiol (CBD) and Pediatric Epilepsy

    University of Colorado, Denver 42 participants Est. completion 2018-09-11 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • No Longer Available NCT NCT02461706

    Treatment of Drug Resistant Epilepsy

    University of Florida 2 sites
    Other conditions: Epilepsy
    View official trial listing →
  • Status unknown NCT NCT02478424

    Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease

    Not yet reported Rabin Medical Center 10 participants Est. completion 2017-06 Stand-alone
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT02487381

    Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids

    Not yet reported Central Institute of Mental Health, Mannheim 60 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Healthy, Modeling Psychosis
    View official trial listing →
  • Withdrawn NCT NCT02492074

    Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study

    Not yet reported Central Institute of Mental Health, Mannheim Est. completion 2025-05 1 site Stand-alone
    Other conditions: Healthy Volunteers, Modeling Psychosis
    View official trial listing →
  • Completed NCT NCT02504151

    Cannabidiol Treatment in Patients With Early Psychosis

    Not yet reported Yale University 18 participants Est. completion 2018-03-09 2 sites Stand-alone
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02539823

    Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans

    Not yet reported Hurd,Yasmin, Ph.D. 45 participants Est. completion 2017-05-24 1 site Stand-alone
    Other conditions: Opiate Addiction
    View official trial listing →
  • Completed NCT NCT02544750

    An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

    Not yet reported Jazz Pharmaceuticals 199 participants Est. completion 2021-06-11 1 site Stand-alone
    Other conditions: Tuberous Sclerosis Complex, Seizures
    View official trial listing →
  • Completed NCT NCT02544763

    A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

    Not yet reported Jazz Pharmaceuticals 224 participants Est. completion 2019-02-26 44 sites Stand-alone
    Other conditions: Tuberous Sclerosis Complex, Seizures
    View official trial listing →
  • Completed NCT NCT02548559

    Sublingual Cannabidiol for Anxiety

    Not yet reported Staci Gruber, Ph.D. 46 participants Est. completion 2025-03-13 1 site Stand-alone
    Other conditions: Anxiety
    View official trial listing →
  • Terminated NCT NCT02551731

    Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms

    Not yet reported INSYS Therapeutics Inc 9 participants Est. completion 2016-09-06 4 sites Stand-alone
    Other conditions: Spasms, Infantile
    View official trial listing →
  • No Longer Available NCT NCT02556008

    Cannabidiol for Pediatric Epilepsy (Compassionate Use)

    University of California, Los Angeles 1 site
    Other conditions: Refractory Childhood Epilepsy
    View official trial listing →
  • Completed NCT NCT02559167

    Cannabidiol and Cocaine Craving/Dependence

    Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 79 participants Est. completion 2019-08-16 1 site
    Substance use disorder Other conditions: Cocaine Dependence, Withdrawal From Addictive Substance; Detoxification
    View official trial listing →
  • Completed NCT NCT02564952

    An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

    Not yet reported Jazz Pharmaceuticals 18 participants Est. completion 2017-06-07 6 sites Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02565108

    A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

    Not yet reported Jazz Pharmaceuticals 20 participants Est. completion 2016-07-21 6 sites Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02607891

    A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

    Not yet reported Jazz Pharmaceuticals 35 participants Est. completion 2018-10-02 5 sites Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02607904

    An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

    Not yet reported Jazz Pharmaceuticals 30 participants Est. completion 2019-05-27 5 sites Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Approved For Marketing NCT NCT02660255

    Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy

    University of Nebraska 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02695537

    University of Alabama at Birmingham (UAB) Pediatric CBD Program

    Not yet reported University of Alabama at Birmingham 89 participants Est. completion 2019-02-27 1 site Stand-alone
    Other conditions: Epilepsy, Seizures
    View official trial listing →
  • Completed NCT NCT02700412

    University of Alabama at Birmingham (UAB) Adult CBD Program

    Not yet reported University of Alabama at Birmingham 80 participants Est. completion 2019-08-08 1 site Stand-alone
    Other conditions: Epilepsy, Seizures
    View official trial listing →
  • Completed NCT NCT02759185

    Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD

    Not yet reported Multidisciplinary Association for Psychedelic Studies 80 participants Est. completion 2019-01 1 site Stand-alone
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT02777502

    Effects of Cannabidiol on Marijuana-seeking in Humans

    Wayne State University 30 participants Est. completion 2019-01-31 1 site
    Other conditions: Marijuana Abuse
    View official trial listing →
  • Terminated NCT NCT02815540

    The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy

    Not yet reported, Not yet reported Gillette Children's Specialty Healthcare 2 participants Est. completion 2018-12-01 1 site
    Other conditions: Lennox-Gastaut Syndrome, Dravet Syndrome
    View official trial listing →
  • Completed NCT NCT02818777

    A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

    Not yet reported University of Colorado, Denver 13 participants Est. completion 2017-11 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT02844933

    Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

    Not yet reported Radius Pharmaceuticals, Inc. 7 participants Est. completion 2019-07-31 7 sites Stand-alone
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT02902081

    Cannabidiol and Emotional Stimuli

    Not yet reported University of Chicago 38 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Drug Addiction
    View official trial listing →
  • Withdrawn NCT NCT02910297

    The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy

    Gillette Children's Specialty Healthcare Est. completion 2017-12-31
    Other conditions: Dravet Syndrome, Lennox Gastaut Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT02926859

    Enhancing Recovery in Early Schizophrenia

    Not yet reported Central Institute of Mental Health, Mannheim 180 participants Est. completion 2027-12 6 sites Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02932605

    Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia

    Not yet reported UMC Utrecht 32 participants Est. completion 2020-01-31 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02953548

    Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)

    Not yet reported Jazz Pharmaceuticals 9 participants Est. completion 2018-05-07 8 sites Stand-alone
    Other conditions: Infantile Spasms
    View official trial listing →
  • Completed NCT NCT02954887

    Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)

    Not yet reported Jazz Pharmaceuticals 9 participants Est. completion 2019-06-13 7 sites Stand-alone
    Other conditions: Infantile Spasms
    View official trial listing →
  • Completed NCT NCT02956226

    Cannabinoids for Behavioral Problems in Children With ASD

    Not yet reported Shaare Zedek Medical Center 150 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Autistic Disorder
    View official trial listing →
  • Completed NCT NCT02983695

    Cannabinoid Therapy for Pediatric Epilepsy

    Not yet reported The Hospital for Sick Children 20 participants Est. completion 2021-07-20 1 site Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02987114

    A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy

    Not yet reported PhytoTech Therapeutics, Ltd. 16 participants Est. completion 2018-06-28 1 site Stand-alone
    Other conditions: Epilepsy Intractable
    View official trial listing →
  • Status unknown NCT NCT03003260

    The Effect of CanChew® Cannabidiol (CBD) Containing Chewing Gum on Irritable Bowel Syndrome

    Not yet reported Wageningen University 40 participants Est. completion 2017-06 1 site
    Other conditions: Irritable Bowel Syndrome
    View official trial listing →
  • Status unknown NCT NCT03005119

    Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms

    Not yet reported PhytoTech Therapeutics, Ltd. 70 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Status unknown NCT NCT03024827

    Cannabidiol in Children With Refractory Epileptic Encephalopathy

    Not yet reported University of Saskatchewan 20 participants Est. completion 2023-12-31 4 sites Stand-alone
    Other conditions: Epileptic Encephalopathy
    View official trial listing →
  • Status unknown NCT NCT03060993

    CAN BREATHE in COPD Trial

    Not yet reported McGill University 16 participants Est. completion 2018-04-30 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD), Breathlessness, Exercise Intolerance
    View official trial listing →
  • Status unknown NCT NCT03078309

    The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients

    Not yet reported Hadassah Medical Organization 50 participants Est. completion 2021-12 1 site
    Obstructive sleep apnea Other conditions: Retinal Degeneration, Cannabis
    View official trial listing →
  • Completed NCT NCT03087201

    CANNAbinoids in the Treatment of TICS (CANNA-TICS)

    Not yet reported Hannover Medical School 98 participants Est. completion 2020-11-20 6 sites Stand-alone
    Other conditions: Tourette Syndrome, Tic Disorders
    View official trial listing →
  • Completed NCT NCT03164512

    The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol

    Not yet reported Johns Hopkins University 19 participants Est. completion 2020-01-22 1 site Stand-alone
    Other conditions: Cannabidiol Pharmacokinetics
    View official trial listing →
  • Withdrawn NCT NCT03172741

    The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis

    Not yet reported, Not yet reported Colorado State University Est. completion 2018-01
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT03196466

    Population Pharmacokinetics of Antiepileptic in Pediatrics

    Assistance Publique - Hôpitaux de Paris 753 participants Est. completion 2023-06-15 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT03215940

    Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)

    Not yet reported University of Utah 53 participants Est. completion 2024-12-01 1 site
    Other conditions: Chronic Pain, Widespread
    View official trial listing →
  • Completed NCT NCT03233633

    Marijuana in Combination With Opioids in Palliative and Hospice Patients

    Not yet reported The Connecticut Hospice Inc. 66 participants Est. completion 2022-08-05 1 site
    Other conditions: Pain
    View official trial listing →
  • Terminated NCT NCT03246113

    Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

    Not yet reported New York State Psychiatric Institute 1 participants Est. completion 2019-05-09 2 sites Stand-alone
    Other conditions: Glioblastoma
    View official trial listing →
  • Completed NCT NCT03248167

    Cannabidiol as a Treatment for AUD Comorbid With PTSD

    Not yet reported, Not yet reported NYU Langone Health 95 participants Est. completion 2022-04-20 1 site Stand-alone
    Alcohol use disorder Other conditions: Post Traumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT03252756

    Effects of Cannabidiol in Alcohol Use Disorder

    Not yet reported, Not yet reported NYU Langone Health 27 participants Est. completion 2022-03-16 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Status unknown NCT NCT03295903

    Cannabinoid Supplementation on Vascular and Cognitive Function

    Not yet reported University of British Columbia 24 participants Est. completion 2021-10-01 1 site
    Other conditions: Diet Modification
    View official trial listing →
  • Completed NCT NCT03328676

    The Effect of Cannabis on Dementia Related Agitation and Aggression

    Not yet reported TO Pharmaceuticals 64 participants Est. completion 2019-08-18 1 site Stand-alone
    Other conditions: Agitation Related to Dementia
    View official trial listing →
  • Terminated NCT NCT03336242

    Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

    Not yet reported Radius Pharmaceuticals, Inc. 20 participants Est. completion 2019-05-29 11 sites Stand-alone
    Other conditions: Childhood Absence Epilepsy
    View official trial listing →
  • Terminated NCT NCT03355300

    Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

    Not yet reported Radius Pharmaceuticals, Inc. 11 participants Est. completion 2019-06-28 9 sites Stand-alone
    Other conditions: Childhood Absence Epilepsy
    View official trial listing →
  • Completed NCT NCT03398083

    Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam

    Not yet reported National Institute on Drug Abuse (NIDA) 42 participants Est. completion 2018-05-30 1 site
    Other conditions: Cannabis Use Disorder
    View official trial listing →
  • Terminated NCT NCT03421496

    A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms

    Not yet reported Radius Pharmaceuticals, Inc. 2 participants Est. completion 2019-05-29 5 sites Stand-alone
    Other conditions: Infantile Spasm
    View official trial listing →
  • Terminated NCT NCT03458416

    A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome

    Not yet reported Radius Pharmaceuticals, Inc. 2 participants Est. completion 2019-07-31 1 site Stand-alone
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT03467113

    A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol

    Not yet reported Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 9 participants Est. completion 2020-06-24 2 sites Stand-alone
    Other conditions: Dravet Syndrome, Lennox Gastaut Syndrome
    View official trial listing →
  • Withdrawn NCT NCT03467620

    Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease

    Not yet reported, Not yet reported University of Illinois at Chicago Est. completion 2019-07 Stand-alone
    Other conditions: Crohn Disease, Inflammatory Bowel Diseases, Cannabis
    View official trial listing →
  • Terminated NCT NCT03471559

    Cannabidiol - an in Vivo Innovative Drug Delivery Study

    Not yet reported Central Institute of Mental Health, Mannheim 8 participants Est. completion 2019-08-29 1 site Stand-alone
    Other conditions: Pharmacokinetics, Bioavailability
    View official trial listing →
  • Completed NCT NCT03537950

    Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder

    Not yet reported King's College London 38 participants Est. completion 2017-03-01 1 site Stand-alone
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Status unknown NCT NCT03549819

    Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

    Not yet reported McMaster University 50 participants Est. completion 2024-02 1 site Stand-alone
    Other conditions: Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia
    View official trial listing →
  • Completed NCT NCT03573518

    Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

    Not yet reported Botanix Pharmaceuticals 368 participants Est. completion 2019-09-05 36 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Status unknown NCT NCT03607643

    A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

    Not yet reported, Not yet reported Leaf Vertical Inc. 160 participants Est. completion 2020-12-15 1 site Stand-alone
    Other conditions: Cancer of Pancreas, Cancer of Liver, Cancer of Rectum, Cancer of Colon, Cancer, Gall Bladder, Myeloma Multiple, Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT03614663

    Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)

    Not yet reported, Not yet reported Zynerba Pharmaceuticals, Inc. 212 participants Est. completion 2020-06-14 21 sites Stand-alone
    Other conditions: Fragile X Syndrome
    View official trial listing →
  • Completed NCT NCT03627117

    Influence of CBD on Episodic Memory in Healthy Subjects

    Not yet reported Prof. Dominique de Quervain, MD 39 participants Est. completion 2018-12-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03634189

    Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-C

    Not yet reported Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud 20 participants Est. completion 2021-12-01 Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03635593

    Cannabis Oil for Chronic Non-Cancer Pain Treatment

    Not yet reported Hamilton Health Sciences Corporation 309 participants Est. completion 2021-01-30 2 sites
    Other conditions: Chronic Non-cancer Pain
    View official trial listing →
  • Available NCT NCT03676049

    Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use)

    John 1 site
    Other conditions: Drug Resistant Epilepsy
    View official trial listing →
  • Completed NCT NCT03679949

    Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia

    Not yet reported New York State Psychiatric Institute 26 participants Est. completion 2022-12-06 1 site
    Other conditions: Pain, Abuse, Drug
    View official trial listing →
  • Completed NCT NCT03693833

    CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.

    Not yet reported Aalborg University Hospital 136 participants Est. completion 2021-06-01 1 site Stand-alone
    Osteoarthritis Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Terminated NCT NCT03763851

    Cannabis Oil and Radiation Therapy for the Management of Pain

    Not yet reported Tetra Bio-Pharma 100 participants Est. completion 2018-11-30 1 site Stand-alone
    Other conditions: Metastatic Prostate Cancer, Lung Cancer, Breast Cancer
    View official trial listing →
  • Completed NCT NCT03787628

    Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder

    Not yet reported University of California, Los Angeles 35 participants Est. completion 2024-03-12 1 site
    Other conditions: Opioid-use Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT03802799

    Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS

    Not yet reported, Not yet reported Zynerba Pharmaceuticals, Inc. 476 participants Est. completion 2026-06-30 26 sites Stand-alone
    Other conditions: Fragile X Syndrome
    View official trial listing →
  • Completed NCT NCT03805750

    Trial of Cannabis for Essential Tremor

    Not yet reported, Not yet reported University of California, San Diego 7 participants Est. completion 2020-11-30 1 site Stand-alone
    Other conditions: Essential Tremor
    View official trial listing →
  • Terminated NCT NCT03808935

    Cannabis Extract in Refractory Epilepsy Study

    Not yet reported The Epilepsy Research Program of the Ontario Brain Institute 17 participants Est. completion 2020-03-15 2 sites
    Other conditions: Drug Resistant Epilepsy
    View official trial listing →
  • Status unknown NCT NCT03813095

    Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction

    Not yet reported Aphios 32 participants Est. completion 2025-12
    Other conditions: Addiction, Opioid Dependence, Opioid Withdrawal
    View official trial listing →
  • Completed NCT NCT03824405

    Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis

    Not yet reported Botanix Pharmaceuticals 200 participants Est. completion 2020-03-04 31 sites
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT03825965

    Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT

    Not yet reported McMaster University 39 participants Est. completion 2025-02-25 2 sites Stand-alone
    Osteoarthritis
    View official trial listing →
  • Withdrawn NCT NCT03826368

    Hemp-Derived Botanical Dietary Supplementation During Recovery From Brain Injury

    Real Time Diagnostics Ventures INC Est. completion 2020-04-13
    Other conditions: Traumatic Brain Injury
    View official trial listing →
  • Withdrawn NCT NCT03832816

    Behavioral and Physiological Effects of THC and CBD

    Not yet reported Johns Hopkins University Est. completion 2021-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT03840512

    An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)

    Not yet reported Kalytera Therapeutics Israel, Ltd. 36 participants Est. completion 2022-12-15 5 sites
    Other conditions: Prevention aGVHD
    View official trial listing →
  • Terminated NCT NCT03848832

    Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

    Not yet reported Jazz Pharmaceuticals 29 participants Est. completion 2021-01-21 26 sites Stand-alone
    Other conditions: Rett Syndrome, RTT
    View official trial listing →
  • Status unknown NCT NCT03875261

    Effect of Cannabinoid (THC / CBD 50%) on Hyperalgesia in Patients With Deep Endometriosis

    Not yet reported David Garcia Cinca 10 participants Est. completion 2019-07-15 1 site Stand-alone
    Other conditions: Endometriosis
    View official trial listing →
  • Status unknown NCT NCT03877991

    Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations

    Not yet reported Hadassah Medical Organization 12 participants Est. completion 2025-02-19 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Withdrawn NCT NCT03883360

    Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis

    Not yet reported University of Maryland, Baltimore Est. completion 2050-03 3 sites Stand-alone
    Other conditions: Schizophrenia Spectrum Disorders, Cannabis Use
    View official trial listing →
  • Terminated NCT NCT03891264

    Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain

    Not yet reported Massachusetts General Hospital 7 participants Est. completion 2020-11-23 1 site Stand-alone
    Other conditions: Back Pain, Low
    View official trial listing →
  • Completed NCT NCT03900923

    Cannabidiol for ASD Open Trial

    Not yet reported NYU Langone Health 29 participants Est. completion 2023-05-04 1 site
    Other conditions: ASD, Autism Spectrum Disorder
    View official trial listing →
  • Withdrawn NCT NCT03904849

    Cannabidiol for Alcohol Use Disorder

    Not yet reported, Not yet reported Medical University of South Carolina Est. completion 2020-04-30 1 site
    Alcohol use disorder
    View official trial listing →
  • Withdrawn NCT NCT03929835

    Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa

    Not yet reported TO Pharmaceuticals Est. completion 2022-09-01 1 site Stand-alone
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT03941288

    Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia

    Not yet reported Mayo Clinic 92 participants Est. completion 2023-02-23 1 site Stand-alone
    Other conditions: Gastroparesis, Dyspepsia
    View official trial listing →
  • Status unknown NCT NCT03944447

    Outcomes Mandate National Integration With Cannabis as Medicine

    Not yet reported OMNI Medical Services, LLC 200000 participants Est. completion 2025-12-31 17 sites Stand-alone
    Other conditions: Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury, Chronic Pain Due to Trauma, Fibromyalgia, Seizures, Hepatitis C, Cancer, Crohn Disease, HIV/AIDS, Multiple Sclerosis, Traumatic Brain Injury, Sickle Cell Disease, Post Traumatic Stress Disorder, Tourette Syndrome, Ulcerative Colitis, Glaucoma, Epilepsy, Inflammatory Bowel Diseases, Parkinson Disease, Amyotrophic Lateral Sclerosis, Chronic Traumatic Encephalopathy, Anxiety, Depression, Insomnia, Autism, Opioid-use Disorder, Bipolar Disorder, Covid19, SARS-CoV Infection, COVID-19, Corona Virus Infection, Coronavirus
    View official trial listing →
  • Completed NCT NCT03948074

    Cannabis For Cancer-Related Symptoms

    Not yet reported Pippa Hawley 91 participants Est. completion 2025-07-23 8 sites
    Other conditions: Pain, Nausea, Anxiety, Sleep Disturbance
    View official trial listing →
  • Status unknown NCT NCT04030442

    Cannabidiol, Morphine, Pain

    Not yet reported Wayne State University 40 participants Est. completion 2025-01-26 1 site
    Other conditions: CBD, Chronic Pain
    View official trial listing →
  • Completed NCT NCT04036968

    Enhancing Medication-based Analgesia in Humans- STUDY 2

    Not yet reported Johns Hopkins University 31 participants Est. completion 2022-11-01 1 site Stand-alone
    Other conditions: Pain, Cannabis, Opioid Use
    View official trial listing →
  • Terminated NCT NCT04039919

    A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol

    Not yet reported UCB Biopharma S.P.R.L. 40 participants Est. completion 2020-05-22 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04044729

    Mechanisms of CBD for Chronic Pain

    Not yet reported University of Utah 24 participants Est. completion 2024-12-01 1 site
    Other conditions: Chronic Pain
    View official trial listing →
  • Completed NCT NCT04045119

    Effect of a Facial Cream Containing Cannabidiol and Hemp Oil on Skin Hydration and Acne-prone Skin

    Not yet reported Avicanna Inc 54 participants Est. completion 2020-01-02 1 site Stand-alone
    Other conditions: Cosmetic Acne
    View official trial listing →
  • Completed NCT NCT04045314

    Effect of an Emollient Cream Containing 0.5% Cannabidiol and 1% Hemp Oil in the Hydration and Erythema of the Skin

    Not yet reported Avicanna Inc 49 participants Est. completion 2019-11-12 1 site
    Other conditions: Cosmetics; Eczema
    View official trial listing →
  • Completed NCT NCT04056442

    A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients

    Not yet reported Stero Biotechs Ltd. 15 participants Est. completion 2022-11-07 3 sites Stand-alone
    Other conditions: Steroid Dependent Crohn's Disease
    View official trial listing →
  • Completed NCT NCT04059978

    Pain Response to Cannabidiol in Opioid-induced Hyperalgesia, Acute Nociceptive Pain and Allodynia By Using a Model Mimicking Acute Pain in Healthy Adults

    Not yet reported University Hospital, Basel, Switzerland 21 participants Est. completion 2020-10-15 1 site
    Other conditions: Acute Nociceptive Pain, Hyperalgesia, Allodynia, Opioid-induced Hyperalgesia
    View official trial listing →
  • Active, not recruiting NCT NCT04075435

    Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

    Not yet reported Mclean Hospital 12 participants Est. completion 2026-12 1 site
    Other conditions: Alzheimer Disease, Anxiety, Agitation,Psychomotor, Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
    View official trial listing →
  • Withdrawn NCT NCT04086342

    CHI-902 for Treatment of Social Anxiety Disorder

    Not yet reported Canopy Growth Corporation Est. completion 2021-01-26 2 sites
    Other conditions: Social Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT04088929

    The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy

    Not yet reported Pure Green 32 participants Est. completion 2019-12-01 1 site Stand-alone
    Other conditions: Diabetic Neuropathies
    View official trial listing →
  • Status unknown NCT NCT04091789

    Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

    Not yet reported Pure Green 30 participants Est. completion 2020-05 1 site Stand-alone
    Other conditions: Dysmenorrhea, Headache, Migraine, Fatigue, Nausea, Mood Disturbance
    View official trial listing →
  • Terminated NCT NCT04129489

    A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis

    Not yet reported Stero Biotechs Ltd. 2 participants Est. completion 2020-03-01 1 site Stand-alone
    Other conditions: Autoimmune Hepatitis
    View official trial listing →
  • Withdrawn NCT NCT04133480

    Investigation of Cognitive Outcomes With Cannabidiol Oral Solution

    Not yet reported Jazz Pharmaceuticals Est. completion 2021-12 Stand-alone
    Other conditions: Lennox-Gastaut Syndrome
    View official trial listing →
  • Completed NCT NCT04192370

    Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine

    Not yet reported Brigham and Women's Hospital 8 participants Est. completion 2021-12-30 1 site Stand-alone
    Other conditions: Opioid-use Disorder
    View official trial listing →
  • Completed NCT NCT04193631

    Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain

    Not yet reported Pure Green 16 participants Est. completion 2019-12-09 1 site Stand-alone
    Other conditions: Musculoskeletal Pain
    View official trial listing →
  • Status unknown NCT NCT04195269

    Osteoarthritis of the Knee Pain Study Using a CBD and THC Sublingual Tablet

    Not yet reported Pure Green 30 participants Est. completion 2020-07-15 1 site
    Osteoarthritis Other conditions: Pain
    View official trial listing →
  • Suspended NCT NCT04197102

    Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder

    Not yet reported University of Texas at Austin 150 participants Est. completion 2025-05 1 site
    Other conditions: Post Traumatic Stress Disorder
    View official trial listing →
  • Terminated NCT NCT04203498

    Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis

    Not yet reported Jazz Pharmaceuticals 139 participants Est. completion 2023-02-28 37 sites Stand-alone
    Other conditions: Multiple Sclerosis (MS)
    View official trial listing →
  • Status unknown NCT NCT04205682

    Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal

    Not yet reported South West Sydney Local Health District 52 participants Est. completion 2021-01 2 sites Stand-alone
    Alcohol use disorder Other conditions: Alcohol Withdrawal
    View official trial listing →
  • Terminated NCT NCT04231643

    Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers

    Not yet reported University of California, San Diego 19 participants Est. completion 2023-11-28 1 site Stand-alone
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT04238754

    Oral Cannabidiol for Opioid Withdrawal

    Not yet reported, Not yet reported Johns Hopkins University 3 participants Est. completion 2022-06-30 1 site Stand-alone
    Substance use disorder Other conditions: Opioid Withdrawal, Opioid Craving
    View official trial listing →
  • Terminated NCT NCT04252586

    A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

    Not yet reported Jazz Pharmaceuticals 21 participants Est. completion 2021-06-09 31 sites Stand-alone
    Other conditions: Rett Syndrome, RTT
    View official trial listing →
  • Withdrawn NCT NCT04267679

    Cannabidiol for Anxiety

    Not yet reported CB2 Insights Est. completion 2020-12-01 Stand-alone
    Other conditions: Anxiety
    View official trial listing →
  • Completed NCT NCT04271917

    Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients

    Not yet reported University of Tennessee 68 participants Est. completion 2022-03-31 1 site Stand-alone
    Other conditions: Pain, Acute
    View official trial listing →
  • Completed NCT NCT04280289

    CBD Cannabis Extract: Pharmacokinetic Studies

    Not yet reported University of Mississippi, Oxford 10 participants Est. completion 2021-12-01 1 site Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT04283019

    The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions

    Not yet reported Johns Hopkins University 75 participants Est. completion 2024-06-17 1 site
    Other conditions: Cannabis, Drug Effects
    View official trial listing →
  • Terminated NCT NCT04286594

    A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety

    Not yet reported Mclean Hospital 15 participants Est. completion 2023-08-24 1 site
    Other conditions: Anxiety
    View official trial listing →
  • Completed NCT NCT04314804

    Safety and Pharmacokinetics of Smoked Cannabis in Healthy Patients

    Not yet reported Tetra Bio-Pharma 48 participants Est. completion 2017-11-16 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT04316598

    Cannabis Effects on Electroencephalography

    Not yet reported Parc de Salut Mar 16 participants Est. completion 2020-07-09 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT04349930

    The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC)

    Not yet reported University of New Mexico Est. completion 2022-09 1 site Stand-alone
    Other conditions: Interstitial Cystitis, Bladder Pain Syndrome
    View official trial listing →
  • Completed NCT NCT04360044

    Efficacy of Inhaled Cannabis for Acute Migraine Treatment

    Not yet reported University of California, San Diego 92 participants Est. completion 2023-02-23 1 site
    Other conditions: Migraine, Cannabis, THC, CBD
    View official trial listing →
  • Completed NCT NCT04387617

    A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones

    Not yet reported, Not yet reported Mayo Clinic 90 participants Est. completion 2022-01-31 1 site Stand-alone
    Other conditions: Urinary Stone
    View official trial listing →
  • Completed NCT NCT04396730

    Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction

    Not yet reported Oregon Health and Science University 9 participants Est. completion 2022-03-02 1 site Stand-alone
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT04398719

    CBD-Microglia PET Study

    Not yet reported Yale University 28 participants Est. completion 2024-12-11 1 site
    Other conditions: CBD, Healthy
    View official trial listing →
  • Withdrawn NCT NCT04412837

    The Use of Cannabinoid Patch for Knee Osteoarthritis

    Not yet reported Northwell Health Est. completion 2024-02 1 site
    Osteoarthritis Other conditions: CBD
    View official trial listing →
  • Terminated NCT NCT04421456

    Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

    Not yet reported Jazz Pharmaceuticals 95 participants Est. completion 2022-03-16 39 sites Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT04428203

    Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer

    Not yet reported Zin W Myint 21 participants Est. completion 2021-08-20 1 site Stand-alone
    Other conditions: Prostate Cancer Recurrent, Prostate Cancer, Prostate Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT04439955

    Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients

    Not yet reported Stero Biotechs Ltd. 15 participants Est. completion 2021-07-30 1 site
    Other conditions: Chronic Spontaneous Urticaria
    View official trial listing →
  • Completed NCT NCT04447846

    Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome

    Not yet reported Anne Comi, MD 11 participants Est. completion 2022-12-09 1 site Stand-alone
    Other conditions: Sturge-Weber Syndrome
    View official trial listing →
  • Completed NCT NCT04461756

    Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers

    Not yet reported Tetra Bio-Pharma 12 participants Est. completion 2018-11-24 1 site
    Other conditions: Healthy Volonteers
    View official trial listing →
  • Status unknown NCT NCT04467918

    CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms

    Not yet reported, Not yet reported University of Sao Paulo 100 participants Est. completion 2021-11-16 2 sites Stand-alone
    Other conditions: SARS-CoV2
    View official trial listing →
  • Active, not recruiting NCT NCT04482244

    RCT of CBD for Anxiety in Advanced Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 60 participants Est. completion 2027-12-01 1 site Stand-alone
    Other conditions: Advanced Breast Cancer, Anxiety, CBD
    View official trial listing →
  • Terminated NCT NCT04485104

    Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

    Not yet reported Jazz Pharmaceuticals 3 participants Est. completion 2025-01-28 11 sites
    Other conditions: Seizure in Participants With Tuberous Sclerosis Complex, Seizure in Participants With Dravet Syndrome, Seizure in Participants With Lennox-Gastaut Syndrome
    View official trial listing →
  • Completed NCT NCT04504877

    Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19

    Not yet reported, Not yet reported University of Sao Paulo 120 participants Est. completion 2020-12-16 1 site Stand-alone
    Other conditions: Covid19, Burn Out, Post Traumatic Stress Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT04517799

    Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism

    Not yet reported University of California, San Diego 42 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Autism, Autism Spectrum Disorder
    View official trial listing →
  • Terminated NCT NCT04527003

    Cannabidiol and Management of Endometriosis Pain

    Not yet reported Milton S. Hershey Medical Center 12 participants Est. completion 2024-06-26 1 site
    Other conditions: Endometriosis, CBD, Pelvic Pain
    View official trial listing →
  • Completed NCT NCT04567784

    Neuroimaging and CBD for Opioid Use Disorder

    Not yet reported Yasmin Hurd 66 participants Est. completion 2025-06-18 1 site Stand-alone
    Substance use disorder Other conditions: Heroin Abuse, Opioid-Related Disorders
    View official trial listing →
  • Withdrawn NCT NCT04569760

    Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

    Not yet reported McMaster University Est. completion 2023-06 1 site
    Other conditions: Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia
    View official trial listing →
  • Status unknown NCT NCT04582591

    Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy

    Not yet reported Zealand University Hospital 54 participants Est. completion 2023-08-30 1 site Stand-alone
    Other conditions: Chemotherapy-induced Peripheral Neuropathy
    View official trial listing →
  • Completed NCT NCT04585841

    The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy

    Not yet reported University of Copenhagen 32 participants Est. completion 2022-11-01 1 site Stand-alone
    Other conditions: Lean Body Mass, Cannabis, Cancer, Nausea, Cachexia, Emesis, Appetitive Behavior
    View official trial listing →
  • Completed NCT NCT04590495

    The Effects of Cannabidiol on the Driving Ability of Healthy Adults

    Not yet reported West Virginia University 40 participants Est. completion 2021-12-01 1 site
    Other conditions: Driving Performance, Cognitive Impairment, Sedation Complication, Mood
    View official trial listing →
  • Withdrawn NCT NCT04592159

    Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder

    Not yet reported, Not yet reported Jazz Pharmaceuticals Est. completion 2023-03 Stand-alone
    Other conditions: Post-Traumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT04601207

    A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population

    Not yet reported New Age Ventures LLC 32 participants Est. completion 2020-11-30 1 site
    Other conditions: Healthy, Cannabis
    View official trial listing →
  • Completed NCT NCT04603391

    Cannabidiol and CES1 Interactions in Healthy Subjects

    Not yet reported University of Florida 14 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT04605393

    Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study

    Not yet reported King's College London 36 participants Est. completion 2023-07-07 1 site Stand-alone
    Other conditions: Schizophrenia, Cannabis Use
    View official trial listing →
  • Completed NCT NCT04607603

    Efficacy of Cannabidiol in Knee Osteoarthritis

    Not yet reported Medical University of Vienna 86 participants Est. completion 2022-03-29 1 site Stand-alone
    Other conditions: Osteo Arthritis Knee, Pain, Joint
    View official trial listing →
  • Status unknown NCT NCT04609748

    Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint.

    Not yet reported Pomeranian Medical University Szczecin 30 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Temporomandibular Joint Disorders, Temporomandibular Joint Dysfunction Syndrome, Temporomandibular Joint Pain
    View official trial listing →
  • Completed NCT NCT04611347

    Is Topical CBD Effective in Treating Thumb Joint Arthritis

    Not yet reported University of Virginia 18 participants Est. completion 2022-05-11 1 site
    Osteoarthritis Other conditions: CBD
    View official trial listing →
  • Status unknown NCT NCT04611438

    Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome

    Not yet reported Yonsei University 107 participants Est. completion 2021-06 1 site Stand-alone
    Other conditions: Dravet Syndrome, Lennox Gastaut Syndrome
    View official trial listing →
  • Withdrawn NCT NCT04613102

    The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial

    Not yet reported, Not yet reported Elena Pope Est. completion 2022-12-30 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Pain, Itch
    View official trial listing →
  • Terminated NCT NCT04615949

    Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors

    Not yet reported, Not yet reported Cardiol Therapeutics Inc. 90 participants Est. completion 2022-11-30 20 sites Stand-alone
    Cardiovascular disease Other conditions: COVID-19, Cardiovascular Risk Factor
    View official trial listing →
  • Completed NCT NCT04634136

    Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy

    Not yet reported University Medical Centre Ljubljana 55 participants Est. completion 2024-02-29 2 sites
    Other conditions: Children, Adult, Spastic Cerebral Palsy, Quality of Life, Cannabis, Physical Disability
    View official trial listing →
  • Completed NCT NCT04657666

    Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

    Not yet reported Jazz Pharmaceuticals 68 participants Est. completion 2022-05-10 16 sites Stand-alone
    Other conditions: Spasticity in Participants With Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT04672252

    The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy

    Not yet reported, Not yet reported NYU Langone Health 100 participants Est. completion 2022-12-16 1 site
    Other conditions: Pain, Postoperative
    View official trial listing →
  • Status unknown NCT NCT04679545

    Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the Feet

    Not yet reported Pure Green 50 participants Est. completion 2021-04-01 1 site
    Other conditions: Diabetic Peripheral Neuropathic Pain
    View official trial listing →
  • Status unknown NCT NCT04686539

    Synthetic CBD as a Therapy for COVID-19

    Not yet reported Sheba Medical Center 50 participants Est. completion 2022-01 1 site Stand-alone
    Other conditions: Covid19, CBD
    View official trial listing →
  • Completed NCT NCT04721691

    Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).

    Not yet reported Northwell Health 16 participants Est. completion 2024-01-17 1 site
    Other conditions: Electrical Status Epilepticus of Slow-Wave Sleep
    View official trial listing →
  • Status unknown NCT NCT04726475

    Impact of CBD-Rich Oil on Aversive Memory Reconsolidation

    Not yet reported, Not yet reported University of Texas at Austin 96 participants Est. completion 2024-01 1 site Stand-alone
    Other conditions: Anxiety and Fear
    View official trial listing →
  • Status unknown NCT NCT04726579

    CBD Oil in Mechanical Back Pain

    perceiveMD 52 participants Est. completion 2021-12-31
    Other conditions: Mechanical Low Back Pain
    View official trial listing →
  • Completed NCT NCT04729179

    Cannabidiol for Fibromyalgia (The CANNFIB Trial)

    Not yet reported Marius Henriksen 200 participants Est. completion 2024-02-14 1 site Stand-alone
    Other conditions: Fibromyalgia
    View official trial listing →
  • Status unknown NCT NCT04731116

    Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection

    Not yet reported, Not yet reported Rabin Medical Center 40 participants Est. completion 2022-04-30 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04731779

    Cannabidiol and Autonomic Function at Rest

    Not yet reported Castleton University 18 participants Est. completion 2021-11-29 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT04732169

    Cannabidiol for Treatment Resistant Depression

    Not yet reported University of Alabama at Birmingham Est. completion 2021-07-09 1 site
    Other conditions: Treatment Resistant Depression
    View official trial listing →
  • Completed NCT NCT04745026

    Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder

    Not yet reported Jazz Pharmaceuticals 103 participants Est. completion 2023-12-21 23 sites Stand-alone
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT04749628

    Cannabidiol for Bilateral Total Knee Arthroplasty

    Not yet reported Hospital for Special Surgery, New York 37 participants Est. completion 2025-01-08 1 site Stand-alone
    Osteoarthritis Other conditions: Pain, Postoperative, Opioid Use
    View official trial listing →
  • Completed NCT NCT04754399

    Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

    Not yet reported University of Michigan Rogel Cancer Center 40 participants Est. completion 2023-10-10 1 site Stand-alone
    Other conditions: Arthralgia, Breast Cancer
    View official trial listing →
  • Completed NCT NCT04760613

    CBD for Chronic Radicular Pain on Chronic Opioid Therapy (COT)

    Not yet reported, Not yet reported NYU Langone Health 14 participants Est. completion 2023-06-07 1 site
    Other conditions: Radiculopathy
    View official trial listing →
  • Withdrawn NCT NCT04768478

    CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF

    Not yet reported NYU Langone Health Est. completion 2023-12-31 1 site
    Other conditions: Ankle Fractures, Tibia Fracture
    View official trial listing →
  • Completed NCT NCT04777643

    Sex Differences in Neural Response to Cannabidiol

    Not yet reported Yale University 19 participants Est. completion 2023-04-27 1 site Stand-alone
    Other conditions: CBD, Neural Responses
    View official trial listing →
  • Status unknown NCT NCT04777981

    (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC

    Not yet reported Anewsha Therapeutics Inc. 60 participants Est. completion 2022-12-28 1 site Stand-alone
    Other conditions: COVID-19, SAR
    View official trial listing →
  • Completed NCT NCT04790136

    Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration

    Not yet reported SocraTec R&D GmbH 18 participants Est. completion 2021-05-12 1 site Stand-alone
    Other conditions: Comparative Bioavailability
    View official trial listing →
  • Status unknown NCT NCT04808531

    NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers

    Not yet reported Medlab Clinical 360 participants Est. completion 2024-06
    Other conditions: Cancer Related Pain
    View official trial listing →
  • Status unknown NCT NCT04820361

    Effect of Cannabinoids on Pain in Fabry Disease Patients

    Not yet reported Albina Nowak, MD 22 participants Est. completion 2023-12-29 1 site
    Other conditions: Pain, Neuropathic
    View official trial listing →
  • Completed NCT NCT04821856

    Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability

    Not yet reported Murdoch Childrens Research Institute 132 participants Est. completion 2025-08-19 3 sites Stand-alone
    Other conditions: Intellectual Disability, Child Behavior Problem
    View official trial listing →
  • Status unknown NCT NCT04831294

    Effects of Cannabidiol (CBD) on the Brain

    Not yet reported Auburn University 15 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: CBD, Fear, Inhibition
    View official trial listing →
  • Status unknown NCT NCT04842383

    Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series

    Not yet reported Gregory L Smith, MD, MPH 40 participants Est. completion 2021-10-04 1 site
    Other conditions: Androgenetic Alopecia
    View official trial listing →
  • Completed NCT NCT04851392

    Do Adolescents and Adults Differ in Their Acute Response to Cannabis?

    Not yet reported University College, London 48 participants Est. completion 2021-06-16 1 site Stand-alone
    Other conditions: Cannabis, Cannabis Intoxication, Cannabis Use, Cannabis Dependence, Marijuana, THC, CBD, Adolescent Development
    View official trial listing →
  • Not yet recruiting NCT NCT04855526

    THC + CBD and Memory Study

    Not yet reported Hartford Hospital 9 participants Est. completion 2026-12-30
    Other conditions: Marijuana Use, Cannabis Use, Cannabis Intoxication
    View official trial listing →
  • Completed NCT NCT04873453

    CBD for the Treatment of Alcohol Use Disorder

    Not yet reported University of Colorado, Denver 45 participants Est. completion 2023-05-31 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Active, not recruiting NCT NCT04878627

    Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa

    Not yet reported University of California, San Diego 40 participants Est. completion 2026-06 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT04881539

    CBD, Immune Function, and Neural Health

    Not yet reported University of Northern Colorado 50 participants Est. completion 2022-03-18 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04899050

    Epidiolex in Typical Absence Seizures

    Not yet reported University of South Florida 14 participants Est. completion 2023-05-27 1 site Stand-alone
    Other conditions: Study the Efficacy of Epidiolex for Typical Absence Seizures
    View official trial listing →
  • Completed NCT NCT04911127

    Therapeutic Response of Cannabidiol in Rheumatoid Arthritis

    Not yet reported University of California, Los Angeles 67 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis, Cannabis
    View official trial listing →
  • Completed NCT NCT04971837

    Interaction Between Cannabidiol, Meal Ingestion, and Liver Function

    Not yet reported Colorado State University 26 participants Est. completion 2021-12-09 1 site Stand-alone
    Other conditions: Metabolism, Liver Function, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT04977986

    Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome

    Not yet reported Harmony Biosciences Management, Inc. 257 participants Est. completion 2025-08-29 27 sites Stand-alone
    Other conditions: Fragile X Syndrome, Fragile X Syndrome (FXS)
    View official trial listing →
  • Completed NCT NCT04978428

    Epidiolex in Obsessive Compulsive Disorder and Related Disorders

    Not yet reported University of Chicago 4 participants Est. completion 2025-11-01 1 site Stand-alone
    Other conditions: Obsessive-Compulsive Disorder, Trichotillomania (Hair-Pulling Disorder), Tourette Syndrome, Hoarding Disorder
    View official trial listing →
  • Completed NCT NCT04982029

    Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder

    Not yet reported Brigham and Women's Hospital 15 participants Est. completion 2022-12-02 2 sites Stand-alone
    Other conditions: Opioid-use Disorder
    View official trial listing →
  • Terminated NCT NCT04984278

    Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

    Not yet reported Jazz Pharmaceuticals 56 participants Est. completion 2022-11-11 30 sites Stand-alone
    Other conditions: Spasticity With Multiple Sclerosis
    View official trial listing →
  • Terminated NCT NCT04989413

    Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine -

    Not yet reported, Not yet reported Hospital Israelita Albert Einstein 110 participants Est. completion 2025-02-20 1 site
    Other conditions: Chronic Migraine, Headache, Overuse Headache Medication
    View official trial listing →
  • Status unknown NCT NCT04992962

    Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee

    Not yet reported Pure Green 66 participants Est. completion 2021-11-14 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT04997395

    Feasibility of Cannabidiol for the Treatment of Long COVID

    Not yet reported Bod Australia 12 participants Est. completion 2023-01-06 1 site
    Other conditions: Long COVID
    View official trial listing →
  • Withdrawn NCT NCT04997616

    Determination of Cannabinoid and Cannabinoid Metabolite Levels in Healthy Volunteers

    Not yet reported University of Arkansas Est. completion 2023-01-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04997954

    EMERALD TRIAL Open Label Extension Study

    Not yet reported Gold Coast Hospital and Health Service 7 participants Est. completion 2024-01 1 site Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis, Cannabis, CBD, Motor Neuron Disease
    View official trial listing →
  • Withdrawn NCT NCT05002114

    Evaluation of a Specific Transdermal Cannabidiol Product for Chronic Musculoskeletal Joint Pain.

    Not yet reported Louisiana State University Health Sciences Center Shreveport Est. completion 2023-01 Stand-alone
    Other conditions: Musculoskeletal Joint Pain
    View official trial listing →
  • Completed NCT NCT05003882

    Radicle ACES: A Study of Commercially Available CBD Used in the Real-world Setting

    Radicle Science 3000 participants Est. completion 2021-12-31 1 site
    Other conditions: Pain, Sleep Disturbance, Anxiety
    View official trial listing →
  • Withdrawn NCT NCT05016284

    Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis

    Not yet reported Applied Biology, Inc. Est. completion 2022-12-15 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT05016349

    Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

    Not yet reported Mahmoud Ramadan mohamed Elkazzaz 160 participants Est. completion 2021-12 Stand-alone
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT05022186

    The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment

    Not yet reported Aristotle University Of Thessaloniki 90 participants Est. completion 2022-12-20 1 site Stand-alone
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT05023070

    Investigation of the Pharmacokinetic Profile of CBD - Phase 1 ANANDA

    Not yet reported Icahn School of Medicine at Mount Sinai 24 participants Est. completion 2023-02-16 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05023759

    Anxiety Symptoms in Relation to Use of Hemp-derived, Full Spectrum Cannabidiol (CBD)

    Formula30A LLC 30 participants Est. completion 2020-10-31 6 sites
    Other conditions: Generalized Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT05032807

    Pharmacokinetic Study of a Novel Lipid Formulation of Cannabidiol Compared to a Standard Formulation

    Not yet reported King's College London 14 participants Est. completion 2022-09-10 1 site Stand-alone
    Other conditions: Absorption; Chemicals
    View official trial listing →
  • Withdrawn NCT NCT05044936

    Topical Cannabidiol Cream and Post-exercise Recovery

    Not yet reported University of New Mexico Est. completion 2023-05-15 1 site Stand-alone
    Other conditions: Muscle Damage
    View official trial listing →
  • Completed NCT NCT05076370

    Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine

    Not yet reported Yale University 7 participants Est. completion 2024-06-28 1 site
    Other conditions: Addiction
    View official trial listing →
  • Withdrawn NCT NCT05097651

    CBD for Sleep in People With HIV

    Not yet reported Mariana Cherner, PhD Est. completion 2023-08-31 1 site Stand-alone
    Other conditions: Sleep Disturbance
    View official trial listing →
  • Terminated NCT NCT05098509

    A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome

    Not yet reported, Not yet reported Radius Pharmaceuticals, Inc. 4 participants Est. completion 2022-10-31 8 sites
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Status unknown NCT NCT05106504

    Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease

    Sheba Medical Center 100 participants Est. completion 2024-08 1 site
    Other conditions: Bladder, Overactive, Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05108220

    Evaluation of Effects of CBD Products on Anxiety Among U.S. Women

    Radicle Science 1350 participants Est. completion 2020-12-30 1 site
    Other conditions: Anxiety, Generalized Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT05115318

    The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome

    Tel-Aviv Sourasky Medical Center 18 participants Est. completion 2021-03-31 1 site
    Other conditions: Tourette Syndrome, Cannabis
    View official trial listing →
  • Completed NCT NCT05132699

    Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder

    Not yet reported, Not yet reported The University of Texas Health Science Center at San Antonio 21 participants Est. completion 2023-06-30 1 site
    Other conditions: Posttraumatic Stress Disorder, Stress Disorders, Post-Traumatic
    View official trial listing →
  • Status unknown NCT NCT05143424

    Evaluation of the Interactions of Cannabidiol (CBD) With Morphine

    Not yet reported National Institute on Drug Abuse (NIDA) 60 participants Est. completion 2024-12-01 1 site
    Substance use disorder
    View official trial listing →
  • Completed NCT NCT05149898

    Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)

    Not yet reported Harmony Biosciences Management, Inc. 20 participants Est. completion 2022-11-09 3 sites
    Other conditions: 22Q11.2 Deletion Syndrome
    View official trial listing →
  • Terminated NCT NCT05159830

    Cannabidiol for Reducing Drinking in Alcohol Use Disorder

    Not yet reported Hôpital le Vinatier 10 participants Est. completion 2026-02-26 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT05170217

    Reducing the Harmful Effects of Cannabis Use: Finding the Optimal CBD:THC Ratio

    Not yet reported King's College London 46 participants Est. completion 2019-06-09 1 site Stand-alone
    Other conditions: Cannabis Use
    View official trial listing →
  • Withdrawn NCT NCT05170451

    Topical CBD for Musculoskeletal Pain

    Not yet reported, Not yet reported University of Virginia Est. completion 2022-12 1 site
    Other conditions: Musculoskeletal Pain
    View official trial listing →
  • Completed NCT NCT05180240

    Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

    Not yet reported Cardiol Therapeutics Inc. 109 participants Est. completion 2025-02-04 37 sites
    Other conditions: Acute Myocarditis
    View official trial listing →
  • Completed NCT NCT05184478

    Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? a Pilot Study

    Not yet reported, Not yet reported Murdoch Childrens Research Institute 10 participants Est. completion 2024-01-04 1 site Stand-alone
    Other conditions: Tourette Syndrome in Adolescence
    View official trial listing →
  • Completed NCT NCT05209867

    Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV

    Not yet reported University of Florida 4 participants Est. completion 2022-12-12 1 site
    Other conditions: Chronic Inflammation
    View official trial listing →
  • Completed NCT NCT05212402

    Assessing the Effects of a Cannabidiol Derived From Hemp Supplement in Healthy Adults

    Not yet reported University of South Carolina 56 participants Est. completion 2022-10-30 1 site
    Other conditions: Healthy, Safety Issues
    View official trial listing →
  • Completed NCT NCT05212493

    The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder

    Not yet reported Assaf-Harofeh Medical Center 128 participants Est. completion 2023-12-31 1 site
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Withdrawn NCT NCT05232123

    Cannabidiol Effects on Cardiovascular System and Exercise Responses

    Not yet reported Castleton University Est. completion 2024-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05233761

    Evaluation of an Oral Cannabidiol (CBD)-Terpene Formulation on Sleep Physiology in Participants With Insomnia

    Not yet reported Defined Research 125 participants Est. completion 2022-07-02 1 site
    Other conditions: Insomnia
    View official trial listing →
  • Completed NCT NCT05240755

    Effectiveness of Cannabidiol vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic Surgery

    Not yet reported Foundation for Orthopaedic Research and Education 40 participants Est. completion 2024-08-20 1 site Stand-alone
    Other conditions: Post-operative Pain
    View official trial listing →
  • Completed NCT NCT05253417

    The CANabidiol Use for RElief of Short Term Insomnia

    Not yet reported Bod Australia 208 participants Est. completion 2023-07-07 2 sites Stand-alone
    Other conditions: Sleep Disturbance, Insomnia, Insomnia Type; Sleep Disorder, Insomnia, Transient, Insomnia Due to Anxiety and Fear, Insomnia Due to Other Mental Disorder
    View official trial listing →
  • Completed NCT NCT05269706

    Investigation of the Pharmacokinetic Profile of CBD

    Not yet reported Yasmin Hurd 60 participants Est. completion 2023-02-16 1 site Stand-alone
    Substance use disorder
    View official trial listing →
  • Status unknown NCT NCT05283161

    CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann)

    Not yet reported, Not yet reported FG Brasil LTDA 40 participants Est. completion 2022-11-20 Stand-alone
    Other conditions: Fibromyalgia
    View official trial listing →
  • Completed NCT NCT05285449

    Influence of Cannabidiol on Glucose Tolerance and The Gut Microbiota

    Not yet reported Christopher Bell 30 participants Est. completion 2024-05-31 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT05288283

    Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

    Not yet reported Jazz Pharmaceuticals 3 participants Est. completion 2023-09-28 14 sites
    Other conditions: Seizures Associated With EMAS
    View official trial listing →
  • Completed NCT NCT05299944

    Reducing Pain and Opioid Use With CBD

    Not yet reported University of Colorado, Denver 126 participants Est. completion 2025-08-19 2 sites
    Substance use disorder
    View official trial listing →
  • Completed NCT NCT05306249

    Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients

    Not yet reported Centre Hospitalier Régional d'Orléans 80 participants Est. completion 2023-02-08 1 site
    Other conditions: HIV Seropositivity
    View official trial listing →
  • Completed NCT NCT05317546

    Cannabidiol in Youth Alcohol Use Disorder

    Not yet reported Medical University of South Carolina 36 participants Est. completion 2024-06-25 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Not yet recruiting NCT NCT05320367

    A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users

    Not yet reported, Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 80 participants Est. completion 2027-12
    Other conditions: Cannabis
    View official trial listing →
  • Completed NCT NCT05324449

    Epidiolex® for Anxiety in Pediatric Epilepsy

    Not yet reported Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 20 participants Est. completion 2025-05-05 1 site
    Other conditions: Anxiety, Epilepsy
    View official trial listing →
  • Completed NCT NCT05345951

    Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use

    Not yet reported Penn State University 1980 participants Est. completion 2026-05-31 1 site Stand-alone
    Other conditions: Underage Drinking, Cannabis Use, Drinking, Teen, Drinking, College, College Drinking, Teen Drinking
    View official trial listing →
  • Completed NCT NCT05346562

    Oral Cannabidiol Effect on Blood Pressure in Hypertensive Patients

    Not yet reported University of Split, School of Medicine 70 participants Est. completion 2022-10-05 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05351905

    Improving Pain Disability With the Use of Oral Cannabinoids

    Not yet reported University Health Network, Toronto 51 participants Est. completion 2026-01-12 1 site Stand-alone
    Other conditions: Chronic Pain, Opioid Use, Cannabis
    View official trial listing →
  • Status unknown NCT NCT05387148

    The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol Dependence

    Not yet reported South West Sydney Local Health District 20 participants Est. completion 2024-06 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Withdrawn NCT NCT05387798

    A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome

    Not yet reported Radius Pharmaceuticals, Inc. Est. completion 2025-08 Stand-alone
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT05388058

    Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

    Not yet reported Mayo Clinic 40 participants Est. completion 2023-07-28 9 sites Stand-alone
    Other conditions: Chemotherapy-Induced Peripheral Neuropathy, Malignant Solid Neoplasm
    View official trial listing →
  • Completed NCT NCT05407285

    A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users

    Not yet reported, Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 70 participants Est. completion 2023-11-14 1 site
    Other conditions: Cannabis
    View official trial listing →
  • Completed NCT NCT05407298

    The Use of Cannabidiol in Cancer Patients

    CHU de Reims 350 participants Est. completion 2022-04-30 1 site
    Other conditions: Cancer
    View official trial listing →
  • Withdrawn NCT NCT05456113

    Topical Cannabidiol Application and Skin Vascular Reactivity

    Not yet reported Penn State University Est. completion 2026-10-01 1 site Stand-alone
    Other conditions: Effect of Drug
    View official trial listing →
  • Active, not recruiting NCT NCT05485831

    Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

    Jazz Pharmaceuticals 111 participants Est. completion 2027-02 18 sites
    Other conditions: Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex
    View official trial listing →
  • Completed NCT NCT05490511

    Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus

    Not yet reported Indiana University 57 participants Est. completion 2025-08-31 1 site
    Other conditions: CBD, Transplant Complication, Kidney Disease, Chronic
    View official trial listing →
  • Completed NCT NCT05494788

    Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)

    Not yet reported Cardiol Therapeutics Inc. 27 participants Est. completion 2024-09-06 8 sites Stand-alone
    Other conditions: Recurrent Pericarditis
    View official trial listing →
  • Completed NCT NCT05498012

    CBD Effects on Periodontal Health of Patients With Chronic Periodontitis

    Not yet reported, Not yet reported Palacky University 90 participants Est. completion 2022-02-01 1 site Stand-alone
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Status unknown NCT NCT05503147

    Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)

    Not yet reported Ove Andersen 17 participants Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Malnutrition, Anorexia, Cannabis, Aging, Emergency Service, Hospital, Renal Function, Pharmacokinetics
    View official trial listing →
  • Status unknown NCT NCT05562635

    CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)

    Not yet reported, Not yet reported Medical University of Silesia 30 participants Est. completion 2023-08-30 1 site
    Other conditions: Temporomandibular Disorder, Myofascial Pain, Orofacial Pain, CBD, Bruxism
    View official trial listing →
  • Completed NCT NCT05571592

    Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

    Not yet reported NYU Langone Health 60 participants Est. completion 2025-12-03 1 site Stand-alone
    Other conditions: Social Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT05574049

    Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips

    Not yet reported Medical Life Care Planners, LLC 56 participants Est. completion 2022-05-04 1 site
    Metabolic syndrome Other conditions: Morbid Obesity, Hypercholesterolemia, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT05600114

    Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

    Not yet reported EmpowerPharm Inc. 239 participants Est. completion 2023-12-13 17 sites Stand-alone
    Other conditions: Social Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT05618756

    CBD, Nutrient Metabolism and Energy Intake

    Not yet reported Loughborough University 15 participants Est. completion 2022-04-30 1 site Stand-alone
    Other conditions: Glucose Metabolism Disorders (Including Diabetes Mellitus), Lipid Metabolism Disorders, Appetitive Behavior
    View official trial listing →
  • Completed NCT NCT05630235

    Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI

    Not yet reported, Not yet reported University of Miami 6 participants Est. completion 2026-08-13 1 site
    Other conditions: SCI - Spinal Cord Injury, Neuropathic Pain
    View official trial listing →
  • Completed NCT NCT05632627

    Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial

    Not yet reported University of Colorado, Denver 43 participants Est. completion 2025-07-07 1 site
    Other conditions: Brain Injuries, Traumatic
    View official trial listing →
  • Completed NCT NCT05644262

    Life's End Benefits of cannaBidiol and tetrahYdrocannabinol

    Not yet reported University of Southern California 120 participants Est. completion 2026-04-28 10 sites Stand-alone
    Other conditions: Agitation, Dementia
    View official trial listing →
  • Withdrawn NCT NCT05646459

    Effect of Local Cannabidiol on Clinical and Inflammatory Outcomes in Periodontal Maintenance Patients.

    Not yet reported University of Nebraska Est. completion 2020-05-14 Stand-alone
    Other conditions: Periodontitis, Adult, Inflammation Gum
    View official trial listing →
  • Not yet recruiting NCT NCT05650697

    Topical CBD Scar Outcomes Study

    Not yet reported University of Oklahoma 22 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Forehead; Wound
    View official trial listing →
  • Completed NCT NCT05651607

    Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa

    Not yet reported Assistance Publique - Hôpitaux de Paris 10 participants Est. completion 2023-11-17 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT05670353

    Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND)

    Not yet reported, Not yet reported University of Sao Paulo 50 participants Est. completion 2024-11-20 1 site
    Other conditions: Endometriosis, Pelvic Pain
    View official trial listing →
  • Withdrawn NCT NCT05672342

    Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

    Not yet reported City of Hope Medical Center Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy, Colon Carcinoma
    View official trial listing →
  • Terminated NCT NCT05678881

    Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy

    Not yet reported Receptor Life Sciences 2 participants Est. completion 2024-02-23
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT05679830

    The Effects of CBD Isolate on Menstrual-Related Symptoms

    Not yet reported Canopy Growth Corporation 33 participants Est. completion 2021-09-23 1 site Stand-alone
    Other conditions: Menstrual Discomfort
    View official trial listing →
  • Active, not recruiting NCT NCT05742724

    The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol

    Not yet reported McMaster University 24 participants Est. completion 2025-03-01 1 site Stand-alone
    Chronic kidney disease Other conditions: Cannabis, Dialysis
    View official trial listing →
  • Terminated NCT NCT05753007

    A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

    Not yet reported Mclean Hospital 2 participants Est. completion 2025-02-11 1 site Stand-alone
    Other conditions: Glioblastoma
    View official trial listing →
  • Status unknown NCT NCT05766969

    Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA

    Not yet reported, Not yet reported Pure Green Pharmaceuticals Inc. 52 participants Est. completion 2023-12-05 1 site
    Other conditions: Diabetic Peripheral Neuropathic Pain
    View official trial listing →
  • Active, not recruiting NCT NCT05772429

    Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting

    Jazz Pharmaceuticals 158 participants Est. completion 2026-07 29 sites
    Other conditions: Seizures
    View official trial listing →
  • Status unknown NCT NCT05774574

    Physiological and Appetitive Effects of CBD Supplementation

    Not yet reported Loughborough University 30 participants Est. completion 2024-01-05 1 site Stand-alone
    Other conditions: Appetitive Behavior, Adverse Effect, Metabolic Health
    View official trial listing →
  • Status unknown NCT NCT05803434

    Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy

    Not yet reported Meyer Children's Hospital IRCCS 30 participants Est. completion 2025-03-01 Stand-alone
    Other conditions: Epilepsy, Rare Diseases
    View official trial listing →
  • Completed NCT NCT05823753

    Cannabidiol to Reduce Anxiety Reactivity

    Not yet reported University of California, San Diego 63 participants Est. completion 2024-08-20 1 site
    Other conditions: Social Anxiety, Social Anxiety Disorder
    View official trial listing →
  • Terminated NCT NCT05832281

    Role of CBD in Improving Alexithymia

    Not yet reported University of California, San Diego 6 participants Est. completion 2025-08-31 1 site
    Other conditions: Alexithymia, HIV
    View official trial listing →
  • Active, not recruiting NCT NCT05836857

    The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

    M.D. Anderson Cancer Center 100 participants Est. completion 2027-05-31 1 site
    Other conditions: Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05840822

    Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia

    Not yet reported Avecho Biotechnology 519 participants Est. completion 2027-12 5 sites Stand-alone
    Other conditions: Insomnia
    View official trial listing →
  • Status unknown NCT NCT05850754

    4 Week Veterans Cannabidiol Intervention

    Not yet reported University of Northern Colorado 100 participants Est. completion 2024-12-31 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05864846

    A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

    Not yet reported Jazz Pharmaceuticals 79 participants Est. completion 2026-04-06 19 sites Stand-alone
    Other conditions: Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
    View official trial listing →
  • Withdrawn NCT NCT05892276

    Effects of CBD Oil on Memory Reconsolidation and Trauma-Related Symptoms

    Not yet reported University of Texas at Austin Est. completion 2025-08-31 1 site Stand-alone
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Status unknown NCT NCT05934500

    CBD Knee Scope Study

    Not yet reported Foundation for Orthopaedic Research and Education 100 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: Post-operative Pain
    View official trial listing →
  • Terminated NCT NCT05942911

    Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis

    Not yet reported Incannex Healthcare Ltd 20 participants Est. completion 2025-10-28 10 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Enrolling by invitation NCT NCT05961501

    The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin

    Not yet reported, Not yet reported Wroclaw Medical University 42 participants Est. completion 2026-12 1 site
    Other conditions: Myalgia, Muscle Pain, Orofacial Pain, Headache, Tension, Headaches Muscular, Headache
    View official trial listing →
  • Status unknown NCT NCT06022874

    The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis

    Phoilex Ltd. 30 participants Est. completion 2023-10-30 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT06037993

    Endocannabinoid Activity Remodulation for Psychosis Liability in Youth

    Not yet reported University of Udine 20 participants Est. completion 2025-11 2 sites Stand-alone
    Other conditions: Clinical High Risk for Psychosis, Ultra High Risk for Psychosis, Attenuated Psychotic Symptoms
    View official trial listing →
  • Completed NCT NCT06069713

    Consumer Perceptions of Cannabidiol (CBD) Health Claims

    Not yet reported Wake Forest University Health Sciences 3504 participants Est. completion 2023-11-20 1 site
    Other conditions: Perceptions
    View official trial listing →
  • Completed NCT NCT06074172

    The Effect of Cannabidiol in Learning and Memory of Adults

    Not yet reported Colorado State University 57 participants Est. completion 2020-11-06 1 site
    Other conditions: Memory
    View official trial listing →
  • Completed NCT NCT06094582

    Knowledges and Use of Cannabidiol in Older Adults

    University Hospital, Toulouse 47 participants Est. completion 2023-12-26 1 site
    Other conditions: Aging, Frailty
    View official trial listing →
  • Status unknown NCT NCT06099171

    Therapy With Paravertebral Oxygen-ozone Injections and Topical Cannabidiol and β-Caryophyllene Patch in Neck Pain

    Not yet reported Humanitas Clinical and Research Center 52 participants Est. completion 2025-03-01 1 site Stand-alone
    Other conditions: Neck Pain
    View official trial listing →
  • Completed NCT NCT06105138

    Cannabidiol Effects on Blood Alcohol Level and Intoxication

    Not yet reported Colorado State University 37 participants Est. completion 2022-03-03 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Not yet recruiting NCT NCT06108349

    Topical Cannabidiol for Treating Carpal Tunnel Syndrome

    Not yet reported University of Virginia 20 participants Est. completion 2027-01-01 Stand-alone
    Other conditions: Carpal Tunnel Syndrome
    View official trial listing →
  • Status unknown NCT NCT06123702

    Cannabidiol Effects on Fear Extinction in Social Phobia

    Not yet reported Hartford Hospital 20 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Social Anxiety Disorder
    View official trial listing →
  • Status unknown NCT NCT06137027

    Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting

    Not yet reported The University of The West Indies 120 participants Est. completion 2024-02-29 1 site
    Other conditions: Postoperative Nausea and Vomiting
    View official trial listing →
  • Completed NCT NCT06192589

    Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions

    Not yet reported Food and Drug Administration (FDA) 241 participants Est. completion 2024-09-06 1 site
    Other conditions: Cannabidiol, Drug Induced Liver Injury, Drug Interaction
    View official trial listing →
  • Completed NCT NCT06206291

    Cannabidiol in the Treatment of Opioid Use Disorder

    Not yet reported Yasmin Hurd 76 participants Est. completion 2024-04-04 1 site
    Substance use disorder
    View official trial listing →
  • Not yet recruiting NCT NCT06222268

    Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery

    Not yet reported, Not yet reported Leslie Lundahl 280 participants Est. completion 2031-09 1 site Stand-alone
    Other conditions: PTSD, Post Traumatic Stress Disorder, Suicide, Cannabis Use
    View official trial listing →
  • Not yet recruiting NCT NCT06261450

    Effect of CBD on the Brain

    Not yet reported Université de Sherbrooke 50 participants Est. completion 2027-12-15
    Other conditions: Fragile X Syndrome
    View official trial listing →
  • Completed NCT NCT06286839

    Study of Cannabidiol (CBD) in Healthy Volunteers

    Not yet reported NextEvo Inc. 26 participants Est. completion 2022-12-14 1 site Stand-alone
    Other conditions: Immune System and Related Disorders, Immune System Diseases
    View official trial listing →
  • Completed NCT NCT06301113

    This Research Study Examines the Effects of Cannabidiol-infused Candy on Reducing the Bacteria Causing Tooth Decay, When Comparing it to a Sugar Free Candy on Adults.

    Not yet reported West Coast University 30 participants Est. completion 2023-02-11 1 site
    Other conditions: Tooth Decay
    View official trial listing →
  • Completed NCT NCT06320327

    Topical CBD's Effects on Soreness and Performance

    Not yet reported Joseph Pastina 30 participants Est. completion 2023-04-30 2 sites Stand-alone
    Other conditions: Muscle Soreness
    View official trial listing →
  • Status unknown NCT NCT06322303

    Effect of Cannabidiol (CBD) on Vision and Driving

    Not yet reported Universidad de Granada 60 participants Est. completion 2025-12-31 1 site
    Other conditions: Cannabis Use
    View official trial listing →
  • Status unknown NCT NCT06353828

    Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients

    Not yet reported CannaMore Biotechs 45 participants Est. completion 2025-04-01 1 site Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT06362889

    Evaluating Microneedling With CBD and Hempseed Oil for Acne Vulgaris Safety and Efficacy

    Not yet reported Rejuva Medical Aesthetics 20 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Acne Vulgaris (Disorder)
    View official trial listing →
  • Status unknown NCT NCT06364254

    Effects of CBD on 2 Mile Run Time Trial Performance

    Not yet reported University of Northern Colorado 30 participants Est. completion 2024-05-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Enrolling by invitation NCT NCT06405646

    Concentration of Receptors With Affinity for Cannabidiol and Cannabinol and the Effect on Chronic Orofacial Pain of Muscle Origin

    Wroclaw Medical University 102 participants Est. completion 2026-12 1 site
    Other conditions: Myalgia, Muscle Pain, Orofacial Pain, Headache, Tension, Headaches Muscular
    View official trial listing →
  • Status unknown NCT NCT06514066

    Cannabidiol's Role in Dementia Management

    Not yet reported, Not yet reported Hospital Pengajar Universiti Putra Malaysia 486 participants Est. completion 2025-10-01 1 site
    Other conditions: Dementia, Vascular, Dementia, Mixed
    View official trial listing →
  • Withdrawn NCT NCT06523725

    Trial Investigating the Safety and Efficacy of BRC-003 in Refractory Post-Traumatic Epilepsy

    Not yet reported Dr. Paul Lyons Est. completion 2025-04-15 1 site Stand-alone
    Other conditions: Post-traumatic Epilepsy
    View official trial listing →
  • Completed NCT NCT06533657

    Unique Treatment of Oncology Pain in Advanced Cancer

    Not yet reported ZYUS Life Sciences Inc. 11 participants Est. completion 2026-04-15 3 sites Stand-alone
    Other conditions: Cancer Pain
    View official trial listing →
  • Suspended NCT NCT06538389

    High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

    Not yet reported City of Hope Medical Center 36 participants Est. completion 2027-01-24 1 site
    Other conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Breast Adenocarcinoma, Breast Ductal Carcinoma In Situ, Estrogen Receptor-Positive Breast Carcinoma, Progesterone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT06570928

    Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease

    Not yet reported Federal University of Latin American Integration 72 participants Est. completion 2025-03-27 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT06578455

    A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions

    Not yet reported dsm-firmenich Switzerland AG 32 participants Est. completion 2024-12-16 1 site Stand-alone
    Other conditions: CBD Pharmacokinetics, Healthy Participants
    View official trial listing →
  • Completed NCT NCT06588972

    Analgesic Effects of a Treatment With Cannabis Sativa Extract in Patients With Knee Osteoarthritis - CANOA (Cannabis for Osteoarthritis)

    Not yet reported Federal University of Latin American Integration 45 participants Est. completion 2024-10-12 1 site
    Osteoarthritis
    View official trial listing →
  • Not yet recruiting NCT NCT06617247

    Effects of Cannabidiol on Burnout Syndrome and Empathy of Caregivers of Older Adults

    Not yet reported University of Sao Paulo 26 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Burnout Syndrome
    View official trial listing →
  • Completed NCT NCT06648031

    Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

    Not yet reported Lexaria Bioscience Corp. 148 participants Est. completion 2025-07-31 7 sites
    Other conditions: Type2diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT06672666

    Use of CBD in the Treatment of Anxiety

    Not yet reported University of Florida 30 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Anxiety, Generalized Anxiety Disorder, Sleep Problems
    View official trial listing →
  • Not yet recruiting NCT NCT06695195

    A Randomized Controlled Trial of Oral CBD for the Treatment of Upper Extremity Musculoskeletal Pain

    Not yet reported Brent DeGeorge 100 participants Est. completion 2026-03 1 site Stand-alone
    Other conditions: Upper Extremity Muscle Pain, Upper Extremity Bone Pain, Upper Extremity Pain
    View official trial listing →
  • Completed NCT NCT06771076

    Effects of a CBD and Natural Ingredients Cream on the Chronic Pain of Triathletes, Runners, Cyclists, and Swimmers

    Not yet reported University of Vic - Central University of Catalonia 35 participants Est. completion 2025-05-16 1 site
    Other conditions: Tendinopathy, Injuries, Chronic Pain, Sports, Physical Activity
    View official trial listing →
  • Not yet recruiting NCT NCT06787118

    Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 130 participants Est. completion 2027-05 1 site
    Other conditions: Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, HR+ Breast Cancer, AI-related Musculoskeletal Pain
    View official trial listing →
  • Completed NCT NCT06800066

    RCT-Consumer Perceptions of Cannabidiol (CBD) Health Claims

    Not yet reported Wake Forest University Health Sciences 460 participants Est. completion 2025-08-15 1 site
    Other conditions: Prevention
    View official trial listing →
  • Completed NCT NCT06804889

    Effect of CBD-Based Vaginal Suppositories on Menopausal Symptoms

    Not yet reported Palacky University 50 participants Est. completion 2024-02-01 1 site
    Other conditions: Menopause and Genitourinary Syndrome
    View official trial listing →
  • Completed NCT NCT06854783

    Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers

    Not yet reported Tiamat Australia Pty Ltd 20 participants Est. completion 2025-10-01 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Not yet recruiting NCT NCT06924827

    A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

    Not yet reported Elizabeth Donner 25 participants Est. completion 2029-06 1 site Stand-alone
    Other conditions: Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)
    View official trial listing →
  • Completed NCT NCT06968910

    CBD-based Therapy to Attenuate Non-bacterial Prostatitis Symptoms

    Not yet reported Palacky University 35 participants Est. completion 2025-01-01 1 site Stand-alone
    Other conditions: Prostatitis
    View official trial listing →
  • Enrolling by invitation NCT NCT06994520

    Efficacy of Topical Cannabidiol for Eczema

    Not yet reported Khon Kaen University 60 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Chronic Pruritus, Eczema, Nummular Eczema, Atopic Dermatitis, Prurigo Nodularis
    View official trial listing →
  • Not yet recruiting NCT NCT07027566

    Effect of an Experimental Cannabidiol Gel on Tooth Sensitivity

    Not yet reported Universidade Federal do Para 75 participants Est. completion 2026-07 1 site Stand-alone
    Other conditions: Dentin Sensitivity
    View official trial listing →
  • Active, not recruiting NCT NCT07091747

    Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase

    Not yet reported, Not yet reported Federal University of Latin American Integration 61 participants Est. completion 2025-12-12 1 site
    Other conditions: Alzheimer Disease (AD)
    View official trial listing →
  • Not yet recruiting NCT NCT07148206

    Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial

    Not yet reported Montefiore Medical Center 40 participants Est. completion 2028-05 1 site Stand-alone
    Substance use disorder
    View official trial listing →
  • Not yet recruiting NCT NCT07148843

    Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving

    Not yet reported, Not yet reported Johns Hopkins University 105 participants Est. completion 2030-10-31 1 site
    Alcohol use disorder Other conditions: Withdrawal From Addictive Substance; Detoxification, Craving
    View official trial listing →
  • Completed NCT NCT07162454

    Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy

    Not yet reported Universidad Complutense de Madrid 23 participants Est. completion 2025-06-30 1 site Stand-alone
    Other conditions: Xerosis Cutis, Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
    View official trial listing →
  • Not yet recruiting NCT NCT07224932

    Tolerability and Efficacy of CBD Extract for RLS Treatment

    Not yet reported University of Colorado, Denver 60 participants Est. completion 2026-02-25 Stand-alone
    Other conditions: Restless Leg Syndrome
    View official trial listing →
  • Completed NCT NCT07301658

    Efficacy and Safety of Revodiol Calming Cream® in Atopic Dermatitis.

    Not yet reported i+Med S.Coop. 42 participants Est. completion 2024-08-07 1 site Stand-alone
    Other conditions: Atopic Dermatitis (AD)
    View official trial listing →
  • Not yet recruiting NCT NCT07326124

    Stratification and Treatment in Early Psychosis Study -ASSIST

    Not yet reported University of Oxford 250 participants Est. completion 2029-09 15 sites Stand-alone
    Other conditions: Treatment Resistant Psychosis, Psychosis
    View official trial listing →
  • Completed NCT NCT07359976

    Pharmacokinetic Evaluation of a Natural CBD Extract

    Not yet reported University of Utah 20 participants Est. completion 2025-01-16 1 site
    Other conditions: Pharmacokinetics of CBD Extract, Oral and Topical Administrations
    View official trial listing →
  • Not yet recruiting NCT NCT07434973

    Stratification and Treatment in Early Psychosis Study - PROMOTE

    Not yet reported University of Oxford 586 participants Est. completion 2031-12-01 19 sites
    Other conditions: Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis, Clinical High Risk for Developing Psychosis
    View official trial listing →
  • Completed NCT NCT07445568

    Home-Based Quadriceps Isometric Exercise for Knee Osteoarthritis Pain

    Not yet reported Universidad del Valle de México, Campus Cuernavaca 50 participants Est. completion 2025-11-01 1 site Stand-alone
    Other conditions: Older Adults (60 - 85 Years Old), OA Knee
    View official trial listing →
  • Not yet recruiting NCT NCT07459920

    Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden

    Not yet reported National Cancer Institute, Naples 156 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Advanced Malignant Solid Tumor
    View official trial listing →
  • Not yet recruiting NCT NCT07462559

    KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study

    Not yet reported Helsinki University Central Hospital 12 participants Est. completion 2026-12-31 1 site
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Not yet recruiting NCT NCT07471347

    Exploring The Effect Of Cannabidiol On Cannabis Tolerance Using A Novel Vaporiser Device In Heavy Users (Stage 1)

    Not yet reported King's College London 10 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Cannabis Intoxication
    View official trial listing →
  • Active, not recruiting NCT NCT07498023

    EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA)

    Not yet reported, Not yet reported Federal University of Latin American Integration 36 participants Est. completion 2026-08-20 1 site
    Other conditions: Fibromyalgia
    View official trial listing →
  • Not yet recruiting NCT NCT07527338

    Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use

    Not yet reported University of Colorado, Boulder 58 participants Est. completion 2031-04-01 Stand-alone
    Other conditions: Sleep, Alcohol Misuse
    View official trial listing →
  • Not yet recruiting NCT NCT07552974

    CBD Supplementation in Brazilian Jiu-Jitsu Athletes

    Not yet reported, Not yet reported Associação Pan-Americana Multidisciplinar de Endocanabinologia 100 participants Est. completion 2027-07-31 1 site
    Other conditions: Pro and Anti Inflamatory Cytokines, Pain, Sleep, Quality of Life
    View official trial listing →
  • Not yet recruiting NCT NCT07564245

    Efficacy of Cannabidiol in the Management of Self-injuries in Children and Adolescents With Severe Neurodevelopmental Disorders.

    Not yet reported Assistance Publique - Hôpitaux de Paris 21 participants Est. completion 2030-02 2 sites Stand-alone
    Other conditions: Neurodevelopmental Disorders With Severe Self-injuries
    View official trial listing →
  • Not yet recruiting NCT NCT07638189

    CBD Knee Osteoarthritis Study

    Not yet reported University of Tennessee 30 participants Est. completion 2028-03-30 1 site
    Other conditions: Osteoarthitis
    View official trial listing →
  • Completed NCT NCT07651930

    Full-Spectrum Cannabidiol Oil for Anxiety and Depressive Symptoms in Parkinson's Disease

    Not yet reported Medical University of Warsaw 27 participants Est. completion 2024-11-17 1 site
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Not yet recruiting NCT NCT07723976

    A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE

    Not yet reported Jazz Pharmaceuticals 120 participants Est. completion 2029-09-04
    Other conditions: Developmental and Epileptic Encephalopathy (DEE)
    View official trial listing →
  • Not yet recruiting NCT NCT07728097

    A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS

    Not yet reported Jazz Pharmaceuticals 40 participants Est. completion 2028-12-28 1 site Stand-alone
    Other conditions: Lennox-Gastaut Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07733791

    Real-world Evidence of Cannabinoid for Observed Pain Relief

    Associação Pan-Americana Multidisciplinar de Endocanabinologia 60 participants Est. completion 2027-07-01
    Other conditions: Chronic Musculoskeletal Pain, Delayed Onset Muscle Soreness (DOMS)
    View official trial listing →
  • Completed NCT NCT07769164

    A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of Various Cannabinoids on Sleep Quality

    Not yet reported Cannabis Science Innovations, LLC 332 participants Est. completion 2024-08-31 1 site
    Other conditions: Sleep Disturbance, Sleep Quality
    View official trial listing →
  • Not yet recruiting NCT NCT07776405

    A Double-Blinded Study on Rapid and Sustained Pain Relief Topical Cannabidiol for Plantar Fasciitis

    Not yet reported University of Florida 50 participants Est. completion 2027-03-31 1 site Stand-alone
    Other conditions: Plantar Fasciitis
    View official trial listing →
  • Not yet recruiting NCT NCT07778810

    Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome

    Not yet reported Johns Hopkins University 10 participants Est. completion 2028-07 1 site Stand-alone
    Other conditions: Sturge - Weber Syndrome (SWS)
    View official trial listing →
  • Not yet recruiting NCT NCT07783295

    Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women

    Not yet reported Associação Pan-Americana Multidisciplinar de Endocanabinologia 80 participants Est. completion 2027-12-01 1 site Stand-alone
    Other conditions: Chronic Pain, Fibromyalgia, Osteoporosis, Orofacial Pain
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Cannabidiol, Epidiolex

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.